>fuscachelin_1
VVTGAGGGIGRAVATALAAQGAAVAAVDVNPESTAQTVTGLAQAGQRGKGYARDVTDTAGVERLFDEIEHDLGPVDILVNAAGILRTGPVVDCPDHDWHDLIAVNATGVFTVSRAAARQMVPRRRGCIITVASNAAGVPRAAMAAYAASKAAAVAFTKSLGLELAPHGIRCNVVSP
>vancomycin_1
ITVLGASGFVGSAVVRALARRPVRVRAVARRRLTPPPGRAEITAVAADLTDRAALAGAVAGSDAIVHLLLGDGGWRGAEGAERVNVGVLRDLVEIAGGGDGPPPVVVFAGTTAQVGVPPREPLDGTEPDHPATPYDAQKLEAEQLLKKATADGLVRGISLRLPTIFGETAAEGANHDRGVVSTMARRALEGLPLTVWGDGTVRRDLVHVDDVASAFMAALD
>t3_toxin_1
IITGASSGIGEATAFALAAEGAKVAIAARRAELLHALAKRIEASGGQALPIVTDITDESQVNHLVQKTKVELGHVDILVNNAGIGVFGAIDTGNPADWRRAFDVNVLGVLYAIHAVLPLLKAQKSGHIVNISSVDGRIAQSGAVVYSAAKSGVNALSEALRQEVSLDNIRVTIIEPGLVDTPFNDLISDPITKQLSKEQLSTITPLQSEDIARAIIYAVT
>mupirocin_1
ICITGASGFLGSHIVEKLLHHGCTVDALLRRPTAHLQGLAARHAQLRLHVVDLAQPGACNALFSECDTVIHCAASVTNNARPGSRLWQQTLEMNVNGTQNVIDGIRQAASVRTFVYTSSMAAILSPDMPAGHAFSEADWNHASLEASDPYWYSKTAAERLVTDAFQPWPCEPRVVCINPSVIIGPVLDPRHAATSIAILHDLHTGKTPACPDLNFHFVDVRDLAELHVRAAL
>mupirocin_2
IIVSGGSQGLGLTTVRCFLEAGYNVATFSRRESPAVTELSERADFHWQALDCTDYSALTAFVQQVEKRFGGLDGLVNNAATGVEGILSTMRVADIDSALDINLKGQLYLTKLVTAKLLKRGAGSVVNVSSINALRGHSGLTVYSATKAAMDGLTRSLAKELGPRGIRVNSVSPGYFSS
>mupirocin_3
VTGGTGFLGSHFIYRHLLTGEFDVTCLVRGRDDNECRHRIRDAVLSAGQHYPATDARLSFAGLKARRADITQPLAGMDIAQSRAQASEQAVFLHFASSLNFEEKNRDIIYEHNINGLTHAFHAAQALGCQTFFYISTAYTAGVGSGEVEECLHQSTEFNNYYEETKCAAEHLIDRLCTASGIELVIIRPSIVIGPQATQS
>ristomycin_1
ITVLGASGFVGSAVTRALARQPIRLRAVARRSVTPPPGPAETTVVAADLTDRAALADAVAGSDAIVYLLLADGGWRVAETEEAERVNLGVMRDLVDVIGAVSGKPPLVIYGGAASQVGVPPREPIDGSETDEPGTPYDKQKLAAEQVLKKATADGLVRGISLRLPTVFGENPAEGANPDRGVVSAMARRALDGQDLTIWGDGTVRRDLVHVEDIAAAFTAAL
>incednine_1
ILVTGAAGFIGSAYVRSLLAPTGPGGDGADVHIVALDLLTYAGRRDNLDLTDRRLTFVHGDIGDTALVAELVATADQIVHFAAESHVDRSIDGAGAFVRTNVLGTQTLLDAALRHGVHRFVHISTDEVYGSIPVGSWPETDPLSPNSPYSASKAGSDLLALAYYRTHGLDVRVTRCSNNYGPRQHPEKLIP
>incednine_2
VVVTGAAGTVGGEIARHLVARHGVRRLLLLSRSGRIPEGLDGSGADITAVACDAADRDALAAALAAVPAEHPVTAVVHAAGVLDDATLATLTPARLDTVLRPKADAAWHLHELTAGQPLTHFVLFSSFASLTGSPGQAN
>incednine_3
VVTGAGSGIGRACALGLLADGWTVVLTGRREEPLYESARLAPAHDQDRAVVLTADVTDPEAVEALFTGV
>incednine_4
VLVTGGTGALGRLVARHLADRHGIRRLLLVSRRGPAAEGAADLVAELADLGARAELVAADLGDRATTEALLAAHPVGAVVHCAGVLDDGVIASQSPERLHTVLAPKADAAWHLHELTRDAGLTAFVLFSSAAGVLGAPGQANYAAANAFLDALATHRRA
>amphotericin_1
VLVTGGTGGIGGRVARRLAEQGAAHLVLTSRRGADAPGAAELRAELEQLGVRVTIAACDAADREALAALLAELPEDAPLTAVFHSAGVAHDDAPVADLTLGQLDALMRAKLTAARHLHELTADLDLDAFVLFSSGAA
>actinonin_1
LVTGAASGIGRAVARRLSAEGACVVVADRNARDAAAVAAELGGPDKAVAVTVDVTREEQIEAAFAEACRAFGGVDLVVNNAG
>mensacaricin_1
VVTGGTKGLGRAITQAFIREGCDVVAAARNADHAEWEMSIGPGKYLFHSVDVQDRASVDALMEYADLHLGGVDIVVANAGVSRPGPAATLPEEAWDEVIGTNLTGVFRCVQAAVPYLERSEHARLITMSSVLAGQVTPGASVYSSSKAAVEA
>mensacaricin_2
ILVTGAGGTLARHVVRALTERGARVRAGSRTPAAVKGLPDGTEVVPLDLAGPHTFAPALEGVDKVFLYCEPRGIEAFTAAARDAGVSHLTVLSSASVIDGRPPTNPIAAHHARVEEVVAASGVPWTFVRVGSLATSALNWAAQVRTGVVRGPYARSEAAPAHEADVAAVAAAALT
>mensacaricin_3
VVTGGSRGIGLAIARGLAGEGVRVVCGASSPAPAPEDSSILTLKVDLSTPEGPQQLADYALEQLGGVDVLVNNVGGG
>arixanthomycin_1
ILVTGGAGFIGSQVVRQLLDAGHDIRVLDALIPDVYRGRAPAELPAEVDFVHGDLRDRATVAQALCGIDLVSHQAAMVGRGREILDVVQYVDCNDLGTANLLAEMISAGVDRMVLASSVVIYGDSRY
>arixanthomycin_2
LVTGANRGLGRAVASCLRKRGYRVVVAARDVGEAGAVAAELGVGVTPAALDVTDPRAVARLAADLSVVDIVVNNAGVLETSGASPASVDLSMVEHEIRVNTLGSWRVAQAFLPGMVARRWGRVVMVSSGTS
>butirosin_1
VFITGANRGLGLSLCEVFLERGHQVLAGVRNMNRAGQLLPLKTKYKEELSIIPVDVSSQDSIRQAYSLITAVTPKLDAIINNAAREGIRCKKIQEVDIADFEETWKTNVLGPMAIIKSLKPMMESSSVKSILNISSEAGSISELPLKTYGYCISKAALNMFTRMLERELKPENFKVVAVHPGWMKTE
>aclacinomycin_1
LGATGCVGRCVSALAREGHEVLAVARRGGPAVAEHLFAGLDVAAVPPAELARLLTGHRVRAVVNVTGGWGTTEEEMRYAHITLVDRLLRALALMDDRPRLVHVGSVHEYGPVPEPLSIGEDLPPRPTTMYARTKLAGSELVLDAARAGRVDALVLRAVNVCGPRTTRASFLGRSPACCGPPTRRTRVTLRLADARRDFVDVRDLAEAVVLAL
>aclacinomycin_2
AEGLAASGHRVRALTRSPSAASLPAGVEVVQGDLERPESLAAALEDVERMYLFPVPETAHEVATLARKAGVRHIVVLSSSSVLSDDEAHHSARHHRTVERAVEDSGAAWTFVRPDEFAVNLLWKWGHSIRTESVVRAPYGRAARALVHEADVAAVAVAALL
>k_252a_1
TGGAGFIGSHFARGLGGAEVTVLDKLTYAGNRANLDGVPHAFVHGDICDAGLLREVLPGHDLVVNFAAESHVDRSIEGAAEFVRTNVLGTQTLLQGCLEAGVRKVVQVSTDEVYGSIGVGSWTESAPLRPRSPYAAAKAGGDLVAQAYAITHGLDVSITRCGNNYGPRQYPEKI
>o_antigen_1
LITGVAGSIGSNLLETLLKLDQKVVGLDNFATGHQRNLDEVRSLASEKQWSNFKFIQGDIRNLDDCNNACAGVDYVLHQAALGSVPRSINDPITSNATNIDGFLNMLIAARDAKVQSFTYAASSSTYGDHPGLPKV
>o_antigen_2
VLVTGATGFIGAALVNSLCSSGQYKVWAGCRRRGGAWPRGVTPLLLGELGSSVVWDAESAIDTVVHCAARVHVMSETASDPLVEFRKANVQGTLDLAREAVSRGVRRFIFISSIKVNGEGTEPGRPYTADSPPNPVDPYGVSKREAEQALLDLAEETGLEVVIIRPVLVYGPGVK
>anglomycin_1
VLVTGGTGALGGHVARWLAVNGAEHLVLTSRRGQDAPGAAALTAELEARGVRVTVVACDVSDCAALAALLDEHPPTAVFHTAGVPHSGAFLDLRTDGMADVYGGKVTGARHLDELTRERDLDAFVLYTSGAGVWGSGGQTAYGAANAALDALAERRRAGGLPATAIA
>laidlomycin_1
VLITGGTGTIGAAVAEHLARTGESGHLLLVSRSGPAAEGAPELAARLGELGAEATFVAADLSEPGAVAELIAGIDPAHPLTGVVHAAGVLDNALIDSQNPERLARVWQAKAATARRLHEATEEARLGMFVMFSSFASTLGTPGQANYAAANA
>vulnibactin_1
FLTGAAKGIGFSVMQHLLEAGARVVATDIDEVRLKTDSDALKNRYREQLFCYHLDLSQPESVARRVAQMIEQHGQFDHLVCCAGVLHLGSITSMPLAQIEHTFNVNTFGTLAVMQALAEGMKARRSGSMVIVGSNAANTPRPNMGAYGASKAALHMLVKSMGMELAEYGVRCNIVSPGST
>alnumycin_1
VVTGATRGIGRSVAASLGALGHPVYLCARDEEALTQTVKELQESGVTADGTVCDVTSAESVQRFVQSAVDRFG
>spectinomycin_1
VAVVGGSGFIGRNLRKALDAAGVRTCSFTRQRPFVQGGRVHRALLRSHTVFYVAGGVTPARAEREPRLAAQDYWNLQLLLWGLRGAAHRPLVVLAGSGGTVYDPEADPPYREDAPTRPVSAYGAVKLAQERALAGAAWTAPVVLRLANVYGPGQSAGAGFGVIPHWAAAVRTGRALTLIGRSRRDYVHVDDVCAALL
>spectinomycin_2
IIVTGGAGFIGSEFVRSMLLAPGAANDIRITVLDKLTYAGVRENLDPVAGHPRHAFVHGDICDGDFLDQVVPGHDAVVHFAAETHVDRSITGSAPFVTTNVLGTQLLLDAARRHGVGRFLHVSTDEVYGSIPVGSWSEESPLAPNSPYAATKAGSELLALACHRTHGMDVVVTRCS
>kanamycin_4_1
VVRALNAARHHVVVASRGYSPALLPEGVRAVRLERTEPDAYTRLVAAEKPDAVIDLTCHDAADAAVTLRACAGVDRVVVVSSVTAAGPATTTPVTEATAAPPLSEYGIDKLAVEETVRAAWADGTSQALLVRLGAVYRLGADLDGQLAEDGCWLAHAAAGAPAVLADDGAARWNLLHADDAGAALAELLA
>brasilinolide_1
VAVLGATGGVGRFVCAAFARAGYDVLAVARRYTAHVYDHEFAPLDVAAADPREIAAVLDAAGVSVVVNATGSWGRTEPELVYAHVTLIERLLAALPLLSRRIRLVHIGSIHEYGPVPAGTLIDETRTPAPTTAYARTKLIGSEAVLDVTHAGVVDGVVLRAVNVCGPGTTSASFLGAVVDKLRAAIPGEVVELTVADARRDFLDVRDLADAVVKAAT
>brasilinolide_2
VLITGGTGGVGAAVARHLIASGATHLVLLSRRGPDAPGAAELRADLAESGATIDIVACDAADPAAFAAVLADLPAPPSLVVHAAGVLDDGLLANQTPERLLATLRAKIDAIAALDAAVADDTEIVVFSSVAGVLGSAGQSTYVAANAA
>s_layer_glycan_1
VLITGGAGFIGSNFVNYMVQKYPSYQIINLDALTYAGNLENVKEVENEPNYRFVKGDITDRELIESLFAEGIDAVVNFAAESHVDRSIADPGIFIKTNVQGTQVLLDAAKKYGVKKYIQISTDEVYGTLGETGYFTETTPLAPNSPYSASKAGADLLVR
>s_layer_glycan_2
IVVTGANGQLGQELVGQLQQTNVELYSFTKSDLDITNDSIVNETITKIKPDILINAAAYTKVDQAEIEEETAYLVNAFGQRNLAIAAEKVGAKICYISTDYVFDGTSMTPYREYDRTNPLGVYGKSKYAGEELTKSLCSRYFIVRTAWVYGEFGQNFVKTMLRLAKEKEEIGVVNDQIGSPTYTVDLARFIIELVQ
>oxytetracycline_1
LVTGGTSGIGLAVVKTLAARGLRVFLCARSRENVDAVVKELRDQ
>FK506_1
VLVTGGTGGLGRLLVDHLLTAHEAAEVVVASRGGRPDGAPADDRVRYVAADVTDRDELAALVDGVAERLCAVVHMAGIVDD
>amicetin_1
VFGARGFIGRHVTAVLAADGWHCTGVDRYGRATDGAGDVGGSYYRGDDWSPVALSRYLRDRGPVLVVNAVGAPWSTDPSVVRRDNAVWPCRLAQACERSGTVTAILHLGSSHEYGDTAPGVPVAESSALAPVTEYGRFKAMGASYLVRAAYRTTRPVTVIRAFNVIGPGHGRNGIWATAAGLYRAAVQEGRSQVVANAPLPETARDLIDVRDVAALV
>paromomycin_1
IVVTGATGGLGGATVEHLLQRVPADQIGVSVREVAKAQHLADRGVRVRQGSYEEPAVLRGSFAGADQVLLVSGNDPTADLVHLHRNAIDAAVAAGARRILYTSQHGAIPGNPYPASDIHRATEAILADCGVAWTALRNGAYGPLDQVLGPWRRTGEIAQPADGPVPYTDRDDVAEAVAVILT
>paromomycin_2
VTGASRGLGLELVRQLLAQGDNVAATTRSPERLTTALGGAADTGRLLALNVDLTDEAQVQHAVDRTTERFGRLDVVVNNAGYGYLAAVEETSAKDVRDMLDVQVVGVWNVLRAALPVLREQRAGRVINISSILGLTTMPGWALYCAGKFALEGLSEALAAEVADFGIKVTVVEPGYFRTSF
>dactylocycline_1
VVLGASGLVGTAVTGLLAARPVHLRTVARHPQPPPPRARAHVEPVAADLTDPAAVRAAVAGADLIVHLVAHRGGWRDAEGNAHVNVGVLDSVLRAAAGARTPPTVVFTGSTSQAGVPARLPIDGTEPDDPRTPYDHQKCAAQALLTAATAAGTVHGVTVRLPTVFGSVSGPGMV
>emulsan_1
ILVTGGAGYIGSHTCIELLNAGHEVIVFDNLSNSSEEALRRVQKLTNKSLVFIQGDIRNQSELDLVFQDHQIDAVIHFAGLKAVGESQQIPLTYFDNNIAGSIQLTKSMEKAGVFKLVFSSSATVYDEVNTSPLNEDMSTGIPNNNYGYTKLIVEQLLQKLAHADRRWSIALLRYFNPVG
>thiomarinol_1
VCVTGASGYLGTHVVAELLAQGYKVIASVRDINSEGVHAMTKAYEEGMFKVMAADFTVAHSLDEALAQSDFLIYCAATTALGFTNDVNVPQAHQSANIIGTGNMIQSIKRCKNLKKVVYSSSMASVFRSDVADDHLYDESDWNNDDKANSEPYFYSKTQAELMLS
>d_cycloserine_1
LVTGANRGMGRDIARQLAERGVHVLLSGRDGAAVAGAAAELRGAGLDVEPLVLDITRTDGIAAAAARIEAEHGRLDILVNNAGIRIEEYGRQPSEQPMGQWRETFDTNLFGVVETTVALLPLLRKSPAGRIVNVSSLLASLATHSDPRSYAYSPMFKSLPAYSASKSALNSWTVHLAYELRETPIKVNAVHPGYTKTD
>monensin_1
VLVTGGTGTIGAAVAEHLARTGESKHLLIVSRSGPAAHGAEELVSRIAEFGAEATFVAADVSEPDAVAALIEGIDPAHPLTGVVHAAGVLDNALIGSQTTESLTRVWAAKAAAAQQLHEATRESRLGLFVMFSSFASTMGTPGQANYSAANAYCDALAALRRAE
>pimaricin_1
VLITGGTGALGARVARELARAGAEHLLLLSRRGPDAPGADALRAELTALGADVTLTACDAADRDALAKVLADIPETSPLTGVVHTAGVIDDGVLDSLTPDRFEDVFRAKAASALALHDLTEDLDLAV
>dihyrdochalcomycin_1
VTGAAGFIGSHFVRQLLSGSYPELADAHVLSLDKLTYAGNTENLAEVAGHPRHTFLHGDICDRSTVTQALRGIDLVVHFAAESHVDRSITDSAAFITTNVLGTHTLLRSALEAGVSRFVHVSTDEVYGSIPEGSSAETDPLDPNSPYAASKASSDLLALAFHRTHGLDVRVTRCSNNYGPHQHPEK
>dihyrdochalcomycin_2
VLVTGALGFIGSHFVRQLDARGAEVLALYRTERPEIQAELAALNRVRLVRTELRDESDVRGAFKYLAPSIDTVVHCAAMDGNAQFKLERSAEILDSNQRTISNLLNCVRDFGVGEVVVMSSSELYSASPTVAAREEDDFRRSMRYTDNGYVLSKTYGEILARLHREQFGTNVFLVRPGNVYGPGDGFDCSRGRVIPSMLAKADAGEEIEIWGDGSQTRSFVHVADLVRASLRLLE
>pristinamycin_1
VVVTGGGTGIGAATARAFADDGAHVLIVGRSESTLKETADGHDRIRILVADVHDHDAPDLIVRTALEEFGRLDVLVNNAAVTGFASLDGLERESVRRQLGTNLLAPVFLTQAALDALEEAGGVVVNVSSAGSLGRRAWPENSVYGMAKVALDFL
>pristinamycin_2
ILVTGATGKVGREAVEQLAAAGRRVRALSRTPEEANLPAGVEVVAGSPADPASLAAAFQGVDSALVVLSGDVAGEARNVAAAAAASGVGHLVFLSSASVLHPLPHGIADEHRAAEEAITASGVDTTFLRPGPFHANTSWWIRTVRESGAVRCWIGNNPGAPIDEYDIASSAVAALTD
>pristinamycin_3
VLVTGATGLQGGATARELVRRGRTVAALVRDPASEAARALADLGVTLVRGDLDDEASLRSAMEGVHGVFSVQTFMTPKGLGGEVRQGRAVARAAKAAGVAHVVYSSVGGAERHSGVPHFESKRHIERYLQELSVPVTVLRPSFFMDNFAAHGPRLVDGTLVVQLALKPDTRVQFIAVEDIGFFAAEAFE
>pristinamycin_4
VLVHGASGGVGTLLTQLAVHAQLRVIGTASPAKHPAVRALGAEPLDYRTEDLPAAVRELAPDGVDAVFDHIGGRGLDAGWAMLADGGTLVSFDSSVAGYRPGQWFRPHVPALRRTAARWIAAKLRLTRGRRQSMYYVKPGDDFRADLAALYRLVDEG
>streptomycin_3_1
LVTGASGMLGRELTPLLDRRGAAVTALGRGHLDITDGAAVRSAVAEHRPAVVVNCAAWTAVDEAESEPALAMAVNGEGPRHLAQACRAVGAVLLQLSTDYVFPGSGGRPYREDHPTGPRTVYGCTKRAGERAVLEVLPDTGYIVRTAWLYGAGGPNFVAKMIRLEAEQDTVLVVDDQHGQPTWTADLADRL
>streptomycin_3_2
LVTGAAGFIGSQYVRTLLGPGGPPDVVVTALDALTYAGNPDNLAAVRGHPRYRFERGDICDAALVDRVMAGQDQVVHLAAESHVDRSLLDASVFVRTNVHGTQTLLDAATRHGVASFVQVSTDEVYGSLEHGSWTEDEPLRPNSPYSASKASGDLL
>chondrochloren_1
LIVGVTGIVGNNLARRLADEGDWAIWGVSRRRPRGFSAVTSLEVDVLDAAATREALAAVAPTHVFFGAWVRTPTETENCRVNGAIVKNVLDAVTAGGSSVRHVALVTGTKHYLGPFESYAQNHPETPFREDQPRLPGENFYYVQEDVVFEHAARSGFGWSVHRPHTIV
>rubromycin_1
ILVTGGSRGIGRGIVLAAARAGADVVTCYRTPGEAVATLEEELAGTPGKHQVLRADAADATDVDRLAAACEASPGGLDAVVNNAGTFRPQPYTDLGPTEWADTLQG
>lomaiviticin_1
VLGAAGYLGSVVTARLAQLPIRLRAASRRRSPLPEQVVAEVEVCTGDLTETERLADVVAGADVILHLGKHSGGWRDADTPEGERVNVGIVRDLIEILGRRRPTRTTPLVVLAATTLQVGQPPKRPMTGSEPDRPETAYGRQKLTAERLLKAAS
>lomaiviticin_2
ILVTGGAGFVGSQYVRNLLDGVYQGYENAEITVLDLLTYAGRRANLPVADRRLTFVRGDIGDRGLLLDLLPGQDAVVHFAAESHVDRSLQDASPFLATNVLGTQNLLECCLRLGIERIVQVSTDEVYGTIAEGAWTEENPLRPNSPYAASKAAADLLARAYHRSYGLPVVITRCTNNY
>dutomycin_1
ILVTGGAGFIGSHYVRAVLAGEYPAYADAEVTVLDKLTYAGNPANLDDVRCELVWGDLCDPELLGKVIPGQDVVVNFAAESHVDRSITGAAEFVRTNVLGVQTLLQACLEAGTPRIVQVSTDEVYGSIDAGSWDEDAPLRPRSPYAASKAGGDLVARAYAITHGLPVSITRCG
>dutomycin_2
VVVGGSGFLGRHICAALTARGARVLSVARRPAPGVPSARIDLVGGPPAALADVLVDHGATVVVNAAGAVWNYDDRALDESNVVLVERLRDAVAKVPHRVRVVHLGSVFEYAMPEPGHPLTEDAPLNPSTAYGRTKLLGSRTVLDATRAGLLDGVVLRATTCAGPGLPPAGLLGRVAAELRTAALRGEPAVIRLAPLTAERDFVDCRDLADAVAAAAT
>nogalamycin_1
VAVVGATGCVGRHVCDAFTRAGHDVVALARRAPAGPGRHPHRFLACDPAGLAPRDLADLFQDARVDTVVNAAGGWLNTEDDNRYHHVRLVERLLAGTALMARTPRLVQIGSVHEYGPVPAGDAVDESREPRPVTVYARTKHAGSQAVLRATRAGDADGVVLRAVNVCGPWVTPASFLGTVTRRLSEAAPGEPVELTLSDARRDFVDGRDLADAVLRAAT
>aureusimine_1
LLTGATGFLGAYLIEALQGYSHRIYCFIRADNEEIAWYKLMTNLNDYFSEETVEMMLSNIEVIVGDFECMDDVVLPENMDTIIHAGARTDHFGDDDEFEKVNVQGTVDVIRLAQQHHARLIYVSTISVGTYFDIDTEDVTFSEADVYKGQLLTSPYTRSKFYSELKVLEAVKNGLDGRIVRVGNLTS
>simocyclinone_2_1
LVTGATSGIGLAVVRALAAQGHQVFFCARNAEKVAVTIKELRGEGLDVDGTSCDVRSVADVKAFVAAAVERFGPVDVLVNNAGR
>simocyclinone_2_2
VAVTGGAGFIGSNFVRDLVGERFAALDVQHVVVLDNLTYAGTLDNLTGVLDDVEFHRTDICDTQAVTRQIVGCDAVVHFAAESHVDRSISSGLPFMRSNVLGTQSVLEAAAAAGAARFVHISTDEVYGSIPVGATGEDAPLAPNSPYAASKAGSDLVALAFARTHGLPVTVTRCSNNYGPYQNPEKA
>stenothricin_1
AVAGASGYAGGELLRLLLAHPQVEIGALTGHSNAGQTLGSLQPHLRPLAGRVLEPTTAEVLAGHDVVFLALPHGQSA
>lobosamide_1
VLVTGGTGGIGAHLTEWLLDQGAERVVLASRRGPAAPGAADLAARLPGVQVVACDVADRDAVAALLDGIGV
>lobosamide_2
VLVTGGTGGIGAHLTGWLLDQGADRVVLASRRGPAAPGAADLTARHPGVEVVALDVADRDAVAALLADLGDELTAVFHAAGVLHQERSLPETSVAEFADVCRA
>lobosamide_3
VLVTGGTGGVGGHVTEWLVGNGAQRVVLASRRGPDAPGAADLTARHPGVEVVALDVADRDAVAALLADLGDELTAVFHAAGVLHPEVPLGQTGLDDFADVCRA
>glidobactin_1
ITGAGRGIGARIAQAALAVGDRVVATGRHVDQLSEAYAAYGERVLCLPLDVAREQDAASAVEVAQSRFGAIDVLVNNAGYGQLGLFEEVASAEVERQFQTNVFGLMHVTRAVLPVMRKQRRGHIMSLSSVGGFMGFEASSIYCAAKFAVEGFSESLALEVAPFNIKVTVIEPGFFRTDFLDQRSVQYGTR
>nataxazole_1
VVTGAAGGIGAEIARALAAAGVPVALLDREPGALRELASELSAAGGTVLAVAADVTDSADVDAAVAKAEA
>indanomycin_1
VVITGGTGALGRLLARRLVKDRGMRRLVLASRSGPEADGATELREELESEGARVSVVACDVTDPDAVAELIAKVPEEHPLTAVVHTAGVLDDGVIETLTRDRLDVVLRAKTDAAVHLHRATRDLPLVDLVLFSSVAGVLGAPGQANYAAANTFLDALAQHRRA
>maklamicin_1
VLITGGTGTLGGLLAEHLVRAGHARRLLLVSRRGGDGAGDLLDRLAEAGAEVTVAACDVSDPAAVAALLAGIPAGHPLTAVFHTAGVVDDAALHTLAPDRLHAVLRPKVDGAWHLHEATRDLPLAAFVLYSSVAGTLGSPGQGNYAAANAFLDALAAHRTA
>acarviostatin_1
ILVTGGAGFIGSAYVRALLGPAGPPGIEVTVLDALTYAGSLTRLESVTGDPRLSFVHGDVLDARSVERLAAQHEDIVHFAAESHVDRSIASGAAFTRTNVMGTQTLLDAVLRQGTRTFVQVSTDEVYGDLPAGAATEDSPLSPNSPYAASKAAADHVALAHHRTHGLDVRVTRCSNNFGAYQHPEKLI
>acarviostatin_2
VLVIGSGFVGTGIARHLAAHGHTVTLASRGRPSTSPTTYGARWAALDATVPEACDRLLTRLRPDGVVLVHGPSDVTWCEEHPGEAEQAHAAVAGNVASLAPGARVVLISTDNVFDGSLPHNTESTPVRPANAYGRAKLRAEQILLATAADAVVLRVSLVYGHEPAGAGKWLNFFASCAHQLLLGEAVHAPDDHWTTPVTVSDVARVTASVL
>vanchrobactin_1
VLLTGAGQGIGYAVLESLLASGYRVVATDRNHHQLTQQLASLNARYTEQLHCYELDLQHHDDVKKRVQELNERYQFDHFISCAGILHLGSITELSMSEIKAMFDVNTFGTLAALQGVTIGMKVRQRGNVIVIGSNSANTPRLNIGAYAASKSALHMLVKCAALELANDGIRCNIVSPGSTRTE
>sphingan_polysaccharide_1
LVTGGAGFIGSAVVRHLVRQGARVINLDKLTYAGNPASLTAIENAPNYRFVHADIADTATILPLLREEQVDVVMHLAAESHVD
>enterocin_1
LVTGGTSGIGLSIAQALLQDGLKVIITGRDPGKLETVVRSLKMEDDQFDVAGYTCDVRDRDAVHDMV
>erythromycin_1
ITLLGASGFVGSAVLRELRDHPVRLRAVSRGGAPAVPPGAAEVEDLRADLLEPGRAAAAIEDADVIVHLVAHAAGGSTWRSATSDPEAERVNVGLMHDLVGALHDRRRSTPPVLLYASTAQAANPSAASRYAQQKTEAERILRKATDEGRVRGVILRLPAVYGQSGPSGPMGRGVVAAMIRRALAGEPLTMWHDGGVRRDLLHVEDVATAFAAALE
>mycinamicin_1
VVVTGALGFIGSHFVEELAARGADVLGLYRSEHRAVRDELSAHDRVRLLPVDLLDERRLRQVFEHEASGAQTIVHCAALDGNAAYKRAHSAEILDANLRVASNLLNCVRDFGVEDVTVLSSAEAYCGPTASPAREDDARCRTVRSGENGYVLSKLITEILAEQYRRQYGFGVHLVRPANVYGPRDSFDGPASRVIPAMIARAESGGEIEIWGDGQQTRSFVYVTDLVRAALALVE
>mycinamicin_2
VLVTGGAGFIGSHFVRQLLAGAYQRWHGAQTIVLDKLTYAGNLANLAPVAHHPDLTFTQGDVCDRELVENLMRGVDLVVHFAAESHVDRSIAAADAFVRTNVQGTHTLLDAAVRAGVERFVHVSTDEVYGSIEEGSWTEEQPLAPNSPYAASKAGSDLLALAFHRTHGLPVCVTRCSN
>colabomycin_1
VLVTGGNRGIGLAVARAFQAQGDAVAVTHRGSGAPEGLLGVECDVTDPDQVARAFGEVEAVQGPVDVLVSNAGITDDRLMLRMTDPQFLRVLDTNLGGAFRTSRKAAAAMLRKRQGRVVFISSVAGLRGSEGQANYAASKAGLVGLARSLARELGSRGITVNVVAPG
>s_layer_glycan_3_1
ILVTGGAGYIGSHTVQALLEQEEQVIVVDNLSTGHQNAVKNVELVQCDIRDKEALGQVFRKYNIEAVVHFAASSLVGESMQNPGKYYDNNLYGTLCLLEIMVQHGVTKIVFSSTAATYGNPEIIPITESEATKPTNAYGETKLAMESMMQWFDIAHGLKYVALRYFNAAGAH
>s_layer_glycan_3_2
ILITGANGQLGMDVLRLFSKKGHEVVGLNRTQLDITDEKLCSDTITELKPDTILHCAAYTAVDNAEKDIDSAYLVNAIGTRNIAAAAERVKAKVCYISTDYVFDGTNTSPYYEYDNTNPLTVYGKSKRAGEQLVQFLCSRWFIVRTSWVYGATGT
>maduropeptin_1
LVTGGSGFIGAHLVDRLVARGDEVTVFDAVPSRDGRGSPREHARHVTGDVRAADALAEVIKPGVDVVYHLAAIVGVDRYLTRPLDVIDINVLGTRNVLELAARAGARVLVASTSEVFGKNPAVPWGEDGDRVLGPTTADRWTYSSSKALAEHMTFAFGRQHGLESRVVRFFNVYGPRQRPAYIV
>novobiocin_1
LVTGAAGMLGRDLVALLRGLNEPVVAITRHDLDITDRLSVRAVVDRHRPTTIVNCAAWTRFGEAEAGESAALLVNGGGARELAAVCRDRSIRLVHLSTDYVFDGTSRRPYAESAVTSPINAYGRTKQAGEQAVLDLLPDDGTIVRTAWLYGRHGMNFI
>novobiocin_2
ILVTGGAGFIGSEFVRATLRGTLPGSSGTQVTVLDKLTYSGNVLNLAPIADLRNYRFVRGDICDQDLVDDVVAGHDAIVHFAAETHVDRSIGSAASFVRTNAMGTQVLLEAASRHRLGRFVHISTDEVYGSIPEGAWDEESPVAPNAPYAAAKAAGDLLALAWHRTHGLDVVVTRCTNNYGP
>salinomycin_2_1
VLVTGGTGALGARVARWLLEHGTTELVLTSRSGPEAPGATALAEELRDGGAKRVEILACDIADRDAVTALLDAHPVDGVVHAAGV
>saframycin_a_1
FLTGATGYLGLHLVEQLLRRTDAEVVTLCRARDEQHALERLKEGFALYEIDVEDQLHRISAVIGDLAEPRLGLTQEQWDDLAATVDVIYHNGALVNFVYPYSALKAANVGGTQRVLELACTTRLKAVHHVSTIDTLLATHMPRPFLENDAPLHSAVGVPAGYTGSKWVAEKVVDEARRRGIPVTVFRPGLILGHTKN
>diutan_polysaccharide_1
LVTGGAGFIGSAVVRHLVRQGARVINLDKLTYAGNPASLTAIENAPNYRFVHADIADTATILPLLREEQVDVVMHLAAESHVD
>pyrrolomycin_1
VVITGASTGIGRACALHLAENGFQVFAGVRKEADGASLERDAKGSLRALLLDVTDQEQIEAAAAEV
>staurosporine_2_1
ITVLGASGFVGSAVVRALARRPVRLRAVARRPCTPPPGPARTTVVRCDLTDRAALADAVAGSDAVVHLLLGDGGWRAAGSEPGAERVNVGVMRDLVEVLRPRPADGAPALVLYGGAASQVGLVPREPLDGSETDRPETPYDRQKLSAEQILKQATAEGRVRGVSLRLPTVFGEGAAPGAVDRGVVSAMARQALAGRTLTLWNDGTVRRDLLHVDDAAAAFTAAL
>staurosporine_2_2
ILVTGGVGFIGSHFVRGRVHEDTVTVLDRLTYAGNPANLEPVAGRFTFVHGDICDAALLKEVVPGHDLVVNFAAESHVDRSIAGAGEFVRTNVLGVQTLLQACLDAGIPRVVQVSTDEVYGSIDTGSWDETAPLSPNSPYAASKAAGDLIALAYARTHRLPVSITRCG
>staurosporine_3_1
ILVTGGAGFIGSHYVRSLLAGEYAAEDAVGAVDASVTVLDKLTYAGNRANLPATHPRLTFVQGDICDQGLLRDLFKGHDAILHFAAESHVDRSVDGGATFVRTNALGTQSVLEAAVAVGVPRVVHVSTDEVYGSIEHGAWTETWPLLPNSPYAASKASADLIARSYWRTHGLDVSITRCSNNYGPYQHP
>staurosporine_3_2
VVLLGATGFVGSAVLRELAVRDVRVRAVSRGAASVPEDARAEIEVHTADLTEPGRLAQAIAGADVVIHTIAYIAGSTTWRINEGDSAAERVNVGLVRDLVAVLRDGDRNLPPLPVVFAGAVSQVGPTDKEVLDGSEPDWPQGEYDRQKLAAERVLLDAHAERILRAVSIRLPTVFGYGPRSTARDKGVVSTMVRRALAGEPITMWHDGTVRRDLLYVEDVARALVAAV
>urdamycin_2_1
VVLGSGGFLGRHIGDAFAAQGARVHAVTRNSSDRTPHGAATGSRTTPIDLLTTPPQEVAEFLGSVGADVVVNAAGRAWRADEAQMTAGNAELVLRLVTALEQVPGPPIRLVQLGSVHEYGAGAPNTGTGEEHEPTPVTAYGRTKLLGTQTVLRAAQDRTVEGVVLRLANVIGAGVPEGSLFGRVAAHLAAAARAESRGEKAAELRLPPLAAARDVVDARDAADAVVAAAT
>urdamycin_2_2
GVSWASGTSDADFAREAALLRDTAKQCAATGRRLLFFSTAATGMYGLAEGPGREDTPVTPCTPYGAHKLALEELLRDSGADHVILRLGHLVGPDQPEHQLLPTLVRH
>jawsamycin_1
LVTGGTAGLGRSLARALADAGARVHVGDHSAPGPERSPSDPERAPQDTSITFTDVDVTDRAALEAWIAAVHAEHGRIDVLIHNAVRMHGAADAEGMTVEQAQSAMRAGYDALVCSVRAVLPLMRSAGGGQIVAVGPGEGRMSGEGAAASCAAVKAAVEAYTEMLRSELAGSGSGIGVTLVRTG
>jawsamycin_2
AVIGGTGLIGSQVVKSLNAAGHEAVPHSQSTGVDVITGKGLDEAVAGADVLVSLTNSPTFDKDSLAFFQTSMDNLLAAGRKGGIRHFVILSIVGVDKVPELDYYKAKVLQEDILAAGAIPYSIVRATQFMEFMDATMSWTTDGDTVRLPPTPIQPIAAKDVADAVAEVA
>malleobactin_1
VLVTGASGFVGSAVARAARQQGHRVRVLVRPTSPRTNVADLDAEIATGDMRDEASMRAALRGVRYLLHVAADYRLWAPDPLEIERANLEGAVATMRAALAEGVERIVYTSSVATLKVTPSGASADESSPLTAEQAIGVYKRSKVLAERAVERMIADDRLPAVIVNPSTPIGPRDVKPTPTGRIIVEAALGKIPAFVDTGLNLVHVDDVA
>lipopolysaccharide_3_1
ILITGATGFIGRSLVPALLSEGHDVRCAVLQLDSTLQAEQIVINNLEVHTDWTDALRNVEIVIHLAARVHIMKEYATSSLDEYCKINSIATKNFVEQAVQNNVKRFIFLSTIKVHGEFSQNNLPFSEDCRTQPEDPYAKSKLYAEQFIQEICQNARMEFVILRPPLVYGP
>lipopolysaccharide_3_2
ILVTGANGQVGTEIIKRFSSSEHEVYACTRDILDCSKLERVHDVLSEIKPDLIINAAAYTAVDKAEDEPDLAHIVNAEFVCRLVNYCTLKNVPLIHLSTDYVFDGEKEGAYHETDIPHPVSTYGRTKWEGEQAILSQLKKYIILRVSWVFGEQGKNFVKTILNLASSRKELNIVSDQSGRPTSARDIARVLFEIVQ
>lipopolysaccharide_5_1
ILVTGGAGYIGSHTAIELLNAGHEIIVLDNFSNASYKCIEKIKEITRRDFITITGDAGCRKTLSAIFEKHAIDIVIHFAGFKSVSESKSEPLKYYQNNVGVTITLLQVMEEYRIKKFIFSSSATVYGEPEIIPIPETAKIGGTTNPYGTSKYFVEKIL
>Sch47554_47555_1
LGGTGFIGRHIGEAFTALGARVHLVSPSAVPRSGATATVRLDVLAASPREIAGLLATVGADTVVNSAGRVWQADEPQMAASNAELVTKVTEALAALPWQPRRPRLIQLGSVHEYGAGTPGGAIAEDWPPAPVTPYGRTKLLGTQAVSRAVRDQDADAVVLRLANVIGPGISVASLFGQVARHLAGAARADSLGEKPDELRLPPLRAARDLVDVRDVADAVVAAA
>Sch47554_47555_2
ILVTGAAGFIGSHFVRNVLEGSYSGWEDAQVTALDKLTYAGNRDNLPASHERLVFVRGDVCDRKLLRELVPGHDAVVHFAAETHVDRSLEGAGDFFRTNVLGTQTLLDAVLDSGVERVVHVSTDEVYGSIDEGSWTEEWPLAPNSPYAASKAGSDLVARAYWRSHGVDLSITRCSNNYGP
>Sch47554_47555_3
VVTGATSGIGLAVTRLLAEQGHRVFLCARTEDGVTRTVKELLDEGLDVDGAVCDV
>tallysomycin_1
VVTGAGGFIGAHLVRFLAQQGCHVRGVDLRHPEFAPSAADEFVTADLRDPAAAADAVAGADVVFALAANMGGIGWTHAAPAEILRDNLLISTNTVEACRAAGVGKVVYTSSACVYP
>aclacinomycin_2_1
LGATGCVGRCVSAALAREGHEVLAVARRGGPAVADYLFAGLDVAAVPPAELARLLTGHRVRAVVNVTGGWGTTEEEMRYAHITLVDRLLRALTLMDDRPRLVHVGSIHEYGPVPEPLSIGEDLPPRPATMYARTKLAGSELVLDAASTGRVDALVLRAVNVCGPRTTRAS
>aclacinomycin_3_1
VLITGGAGFIGSHYVRSLLAGTLPGPRPSRVTVVDLLTYAGDTGNLPLADPRLDFRRLDIRDLDALLTVVPGHDAVVHFAAETHVDRSLSEPAEFVRTNVLGTQSLLEASLRGGVGTFVHVSTDEVYGSIAQGTWTEEAPLLPNSPYAASKAGSDLVARSYWRTHGLDVRTTRCANNYGPRQHPEKL
>aclacinomycin_3_2
VIVTGGGTGIGRATAHAFADRGDRVLVVGRTAATLAGTAEGHPGISVLTADLTDPDGPRAITDAALDALGRIDVLVNNAATGGFAGLAETEPEAAREQFDSNLLAPLLLTRQTLDALSADGGGTVLNIGSAGALGRRAWPQNGVYGAAKAGLDFLTR
>prodigiosin_1
VLVLGATGFIGGHLTRRLAESGRRVRVLARPGSDRSGLEGLPVETVTGSLDDLDSLRRAARGVRHVYNCAGLSADWGSWDSFRKVNVDGARNAVLACEHAGTVERLLHVSTTDVYGYPALPCDESAGVQDIGLPYNRSKLRGEAAVRQAAKRAGLPYTIVRPVSVYGPRSKDFVI
>FR901464_2_1
LVGGMGGIGQHVARDLAARGLRVTISGRSVDPAAWRAFRETASTAGERLDALAVDIADADDVKRAVASIVAKHGRIDAVIHSAGVIGDAYLRHGRAVDAEPVFASKLRGGANLDDATRDLDLKCFVLFSSLSALGSPGQAAYAV
>glycopeptidolipid_3_1
VLITGGAGFIGSALAQRLTHEGYEVAVMDLLHPQVHARGSKVDLPRSVRLFTGDVTHAPDWDAVLRLFQPAQVVHLAAETGTAQSLSEATRHSSVNVVGTTQLLDALSRADLVPDQIVLASSRAVYGEGEWRTATDSTFYPLPRSHAQ
>vicenistatin_1
LVTGAAGFIGSAYVRGLLTDQPDLRVTVLDSLTYAGNRANLDLTHPSLDLVEGDICDTELVDRLTAEADQIVHFAAESHVDRSITGSAEFIRTNVLGTHTLLDAALRHGIDRFVHISTDEVYGSIEKGSWPETDPLRPNSPYSASKASSDLLALAYHRTHGLDVRVTRCSNNYG
>FR901464_1
LVGGMGGIGQHVARDLAARGLRVTISGRSVDPAAWRAFRETASTAGERLDALAVDIADADDVKRAVASIVAKHGRIDAVIHSAGVIGDAYLRHGRAVDAEPVFASKLRGGANLDDATRDLDLKCFVLFSSLSALGSPGQAAYAV
>glycopeptidolipid_2_1
LISGGAGFIGSALSNRLIQAGYDVAVMDVLHPQVHARGRAIDLPASVRLFTGDVTHAPDWDAVLRLFEPSQVVHLAAETGTAQSLSEATRHGSVNVVGTTQLLDALSRSALVPDQLVLASSRAVYGEG
>rubradirin_1
LVTGGAGFIGSHYVRQLLAGGYPGYEQARITVLDVLSYAGRRDNLPVDHPRMDFVQGDICDIPLLLDLLPGHDAVVHFAAESHVDRSVRSAAEFVRTNVAGTQALLEASVRRGISRFVHVSTDEVYGSTDEGSWTEDAPLLPNSPYAASKASADLITRAYWRTHGLDVSITRCSN
>rubradirin_2
VLVTGAYGGVGSHVVAGLLSAGVPVRGTSRTPRTGESPDGAEMVRLDLDEPETWPAALDGVKKVFLYAHADRVADFAGAARAAGVEHIVLLSSAAVVDPATRHSRSAVMHSAVEEALRESGIAWTFLRPTTFATKQLHLAPAIRSGEVLRIPFLQAPTASIHERDIADAAVCALT
>rubradirin_3
VLVTGAYGDVGSHVVAGLLSAGVPVRGTSRTPRTGESPDGVEMVRLDLDEPETWPAALDGVKKVFLYAHADRVADFAGAARAAGVEHIVLLSSAAVVDPATRHSRSAVMHSAVEEALRESGIAWTFLRPTTFATKQLHLAPAIRSGEVLRIPFLQAPTASIHERDIADAAVCALT
>rubradirin_4
IVVLGGSGFIGAAVVEALARRPVRLRTVGRRPQPVPAGAVADIETVCADLTGRAALEAAVAGADTVVHLLMHTADWREAAGNPAAEEVNVGVMRDLVGLLGNTRRPPAVLFAGSTSQAGLPERMPIDGSEPDRPTTAYDRHKHTAEQILKAAD
>exopolysaccharide_6_1
VFVTGVNGQLGHDVMNELAKRGYEGVGSDLAPEYAGVADGTAVTEAPYVSLDITDADAVDKVISEVNPDVIVHCAAWTAVDMAEDDDKVAAVRKVNVDGTQNIANVAKKLDAPMVYLSTDYVFDGQGTTPWEPDFKGYKPLNVYGETKLGGEEAVANTLDKYFIVRIAWVFGVNGSNFIKTMLKVGSNHDEVKVVSDQVGTPTYTFDLARLLVDMIE
>exopolysaccharide_5_1
VFVTGVNGQLGHDVMNELAKRGYEGVGSDLAPEYAGVADGTAVTKAPYVSLDITDADAVDKVISEVNPDVIVHCAAWTAVDMAEDDDKVAAVRKVNVDGTQNIANVAKKLDAPMVYLSTDYVFDGQGTTPWEPDFKGYKPLNVYGETKLGGEEAVANTLDKYFIVRIAWVFGVNGSNFIKTMLKVGSNHDEVKVVSDQVGTPTYTFDLARLLVDMIE
>5_hydroxystreptomycin_1
ILLTGHQGYLGTVMAPVLTAAGHQVTGLDSGLFASRVLGALDVPDVPGLALDLRDVTVDTLRGYDAVVHLAALSNDPLGSLDPELTHAVNHHASTRLARLAKEAGVTRFAYASTCSVYGAQSGDAPVDEDAPLKPVTPYAVSKVRVEDDLVELADSGFAPFFLRNATAFGFSPRLRSDIVLNNLVGRAVLGGRVTVLSDGTAWRPLVHAEDIARAVLA
>5_hydroxystreptomycin_2
LVTGGAGFIGSHYVRTLLGPDGPPDAVVTVLDALSYAGNLANLDPVRDHPPVRFVHGDICDADLVRVMAGQDQVVHLAAESHVDRSLLDAAAFVRTNAGGTQTLLDAALRHGVAPFVQVSTDEVYGSLETGSWTEDEAVRPNSPYAASKASGDLLALAMHVSHGLDVRI
>5_hydroxystreptomycin_3
LVTGASGMLGRELTARLSRRGVPVVPLVRRADLDVTDPAAARALLARHRPAVLVNCAAWTAVDAAEAHEARALAVNGEGPGHLARACRATGTRMIQLSTDYVFAGLADRPYREDDPPAPRTAYGRTKLAGERAVLDTLPDGGYVVRTAWLYGSGGANFVSTMIRLA
>frenolicin_1
LVTGATRGIGLAVAEALVARGYPVVVCARDAEAVARTVKELAAGGARVEGVVADVTDAASVHELVA
>frenolicin_2
VLVAGASGAVGGRLVSRLLDSGVPVRALVRSAARGRALAAVGAETVVGDLADTASLAAALHGVERAFLLLQDEAGAPFARAAAKARGLREVVVLSATAAAHPEYDNPMFQKHVRGERHVRGSGVPWVFLRPGAFASLALLWAPALHGDGVVRVPHAGLAVPLIDPRDIADVAAAVLT
>spliceostatin_1
LVGGMGGIGQHVARDLAARGLRVTISGRSVDPAAWRAFRETASTAGERLDALAVDIADADDVKRAVASIVAKHGRIDAVIHSAGVIGDAYLRHGRAVDAEPVFASKLRGGANLDDATRDLDLKCFVLFSSLSALGSPGQAAYAV
>cinerubin_1
GRHVAERVAASGHRVRALTRSPETAGLPAGVEVVRGDLERPETVRAALEGIDRMYLFPVPETAREVAELAREAGVRQIVVLSSSSVLEDESNPSHRHHRAVERAVEDSGVGRTFVRPDEFAGNTLWKWGESIRERGVVSAPYGQAARAVVHEADIAAVVAAALL
>cinerubin_2
VVTGATSGIGLAVARRLAEEGARVFICARDGDRLAHTVKELRDTGLDIDGVSCDVRDTEQVRAFVAAATERFGPVDVLVNNAGRSGGGPSASLTD
>cinerubin_3
VAVLGATGCVGRRVAATLEREGYEVLAVARHHAPAVAGRLFAGVDVAAVPPAALAALLARHRVRAVVNVTGGWGTTEEEMRYAHITLVEQLLAALELTPGRPRLVHVGSIHEYGPVPEPAAIAEERVPRPDTSYARTKLRGSELVLDAARSGRVEALVLRAVNVCGPHTTRASFLGSVVERLRAAAPERPVALRIADARRDFVDVRDLAEAVVLAV
>cinerubin_4
VIVTGGGTGIGRATARAFAARGDRVLIVGRTPATLDATAEGHPGIHVLTADLTTPDAPRTVIRAALETFGRVDVLVNNAATGGFASLAATEPQAARAQFEGNLLAPLLLTRQALDALAADGGGTVLNIGSAGALGRRAWPENGAYGAAKAGLDFLTR
>cinerubin_5
ITGGAGFIGSHYVRSLLAGELPGPRPDRVTVVDLLTYAGNTDNLPLADSRLDFRKLDICEHDALLKVLPGHDAVVHFAAETHVDRSLTNAAAFVRTNVLGTQSLLEASLACGVATFVHVSTDEVYGSITEGTWTENEPLLPNSPYAASKAGSDLVARSYWRTHGLDVRVTRCANNYGPRQHPEKLIP
>meridamycin_1
LVTGGTGALGRQVARWLVDSGLERVVLTSRRGGEAPGAVELVAELGSRVRVVACDVGDREELAALLAMLPDVRTIVHAAGVLDDGVLESLTPERIREVMRAKADGARHLHELTRDIDLDAFVLFSSAAGTVGNAGQGSYAAANAVLDGLAWRRRAEGLVATS
>meridamycin_2
LVTGGTGALGRQVARWLVGSGLERVVLTSRRGVEAPGAVELVAELGSRVRVVACDVGDREELAALLVTLPDVRTIVHAAGVLDDGVLESLTPERIREVMRAKADGARHLHELTRDIDLDAFVLFSSAAGTVGNAGQGSYAAANAVLDGLAWRRRAEGLVATS
>meridamycin_3
VLVTGGSGYLGTHVISGLLRSGHRVRTTVRSHGPATGAAASVRSAIAASGVDPGGRLDIVSADLTTDDGWDDAMAGCTRVHHVASPFPAVQPDNADELIVPARDGTLRVLRAARDQGVKRVVMTSSFAAVGYSHKDGDEYDESDWTDPEDDNPPYIRSKTIAELAAWDFVAKEGDGLELTVINPTGIFGPALGPRLSASTEHVRAMLEGAMSAVPRAHFGMVDVRDVAELHLRA
>tiancimycin_1
LVTGASSGIGEAVALALAERGAHVTLVARRADRLRQVAEKITGNGGEAHAVQADLGEEPGAHAAVEAAVGAAGRLDIVVNNAGVLLLGPVEDAPTDEWWRMVRLDLMGVALVTRAALPHLLRAARSAPRQVADVVNVSSVGGRIATPGTAVYNAAKAGVNAFSESLRQEVTRRYVRVSVIEPGFVATELPLQSRPEVLAALADGFDPGPPLAPADVADAIAYTVT
>mitomycin_1
VVVSGASGQIGGACALELAALGATVVAGYHSGEQAIRKLREQVEGQGGTLVPVAADLSEPEGADALVAAAVERFGRVDGCVAAAGLRTRRLAMATDARSLEKLLRVNLAGSVGLAKACLKPMMRARYGRIVLFGSRAGTSGLPGHSAYAATKGALQPWAASVAGEVGKHGITVNVVAPGAI
>chelocardin_1
LVTGATSGIGLAVTKALAARGLRVFICARNRENVVSTVKELRAQGLDVDGQAGDVRS
>herboxidiene_1
LVTGATGYIGGRLVPELLEAGHTVRCLARTPGKLRDHPWAERVEIVQGDVTDAASVGAAMRGIDVAYYLVHALAAGPGFEATDRTAARVFGERARAAGVRRIVYLGGLTPDDVPVAELSPHLRSRAEVGRILLDSGVPTTALRAAVIIGSGSASFEMLRYLTERLPVMVTPSWVSTRIQPIAVRDVLRCLVAAA
>lipomycin_1
LVTGAAGFIGSAFVRSSLTQPGSAFPEMEITAFDALTYAGNTENLSSVADDPRFTFVRGDIADGKLLAEVLPGHDIVLNFAAETHVDRSIEGPSVFVRTNVLGTHTLLEAARRAGVERFVQISTDEVYGSIDTGSWTEESALCPNSPYAAAKAGADHLA
>lipomycin_2
VVVTGGLGFIGSHFVEQLLEHGACVTCVHRGEKPEVLEVLPSANRARLLSLDLLDDTALSAALRSVTPRVDLIVHCAALYGNADFKKRNPALILDANMRMASNVLRAARACDVGDVVMMGSAEIYSELAPSPAREDDDYRRYPVPTQNGYALAKIYTEMLAEFFRTQYGMRIFVPRPTNVYGPRDDFDASVSRVVPSLMNRIARGEDIEIWGDGSQTRTFVHVRDVVRATLRMAE
>niddamycin_1
VLLTGCTGALGRRVAVHLARRHGVRRMLLVSRSGPNAPESAALERELTELGVHTSFVSCDLADPADVRKAVAGVPSDHPLTGVVHTAGVLDDGALARLTPERIDTVLRAKADAVRHLHEATLGHPLRAFVLFSAAAGLLGRPGQASYAAANAV
>coumermycin_1
LVTGAGGMLGRDLVRVLEALNEPVLAATRQDLDITDRFSVRAVVSRYRPTAIVNCAAWTRFHEAETSEAEAHLINGRGARELATICGDRSIRLVHLSTDYVFDGASRRPYAESAATGPINAYGRTKLAGEQAVLELLPDDGTIVRTAWLYGRHGTNFL
>coumermycin_2
LVTGGAGFIGSEFVRATLRGVLPGSSGTQITVLDKLTYSGNELNLAPIADLETYRFVQGDICDRGLVDDVVAGHDAIVHFAAETHVDRSIEGAASFVRTNALGTQVLLEAASRHRLGRFVHISTDEVYGSISEGAWTEASPVAPNAPYAAAKAAGDLLALAWHRTRKLDVVVTRCTNNYGP
>SF2575_1
VITGGTRGLGRAIAERYLDEGASVVCAARNPYRIDQLVEQLPDRVMYHETDVTSPESVEGLLEAAARTFGRVDILVANAGVNRDGKVDRLAVDDWRAMVDTNLSGTYFSLRAAARLMTAQGSGRIVTVSSSMASRVAVGAGGYSATK
>SF2575_2
ILVTGGAGFIGSHYVRTLLGPGGPGDVSVTVLDKLTYAGNPANLDEVRGHPGFSFVHGDILDGALADKLMAEHQHVVHFAAETHVDRSIDGGARFVHTNVSGTHTLVDAAHRAGVATFVHVSTDEVYGSIESGSWPETHPLAPNSPYAASKASSDLVALSYHRTHGLDVRVTRC
>echosides_1
ILVTGATGQVARPVAEALAGRNEVWCLGRFGTPGVEKELTDQGITTFHWDMNDQGPAAYEGLPDDFTHVFHSAVRRGEDGDVNAAIEVNSVATGRLMTHCRSAEAFLFVSTGALYKRQTLDHAYSEDDPVDGVADWLPAYPVGKIAAEGAVRAFAQVLGLPTTIARLNIAYGP
>landomycin_1
ILITGGAGFIGSHYVRTLLNDGYEDWKGAHVTVLDKLTYAGNRDNLPEAHPRLTFVQGDICDFELLLELLPGHDAVVHFAAESHVDRSLESAEEFVHTNVTGTQRLLDAVLATRVKRVVHVSTDEVYGSIDEGSWTEEWPLAPNSPYSASKAASDLLARSYWRTHGLDLSITRCSNNYGP
>landomycin_2
GVSWASGTSDADFAREAALLADVAVRCRATGRRLLFFSTAATGMYGAMDGPGREDSHIVPCTPYGAHKFALEQQLRASGADYLILRLGHLVGPGQPAHQLIPALIRQMREGDVRVQRDAARDLIDVRDVVTVI
>polyketomycin_1
VVVGGSGFLGRHVCAALTAHGARVLSVARRPAPGVASARIDLVGGPPAALADLLVEHGATVVVNAAGAVWDYDGRALDEANVTLVERLRDAVAKVPHRVRLVQLGSVFEYEMPARGRPLTEEAPTDPSTAYGRSKLRGSEIVLDATRAGLLDGVVLRATSCAGPGLPRSSLLGRVAARLRDAAVRGEPAVVTLAPLTAERDYVDCRDLAAAVAAAAT
>polyketomycin_2
ILVTGGAGFIGSHYVRAVLAGEYPAFADAEVTVLDKLTYAGNPANLGEVRCEFVWGDLCDPELLSKVIPGQDVVVNFAAESHVDRSIAGSAEFVRTNVLGVHALLQACLEAGTPRVVQVSTDEVYGSIDAGSWDEEAPLRPRSPYAASKAGGDLVARAYAVTHGLPVSITRCGNNYGP
>ravidomycin_1
ILVTGGAGFIGSTYVRTLLGPDGPGDVKVTVLDRLTYAGNPANLDPVREHPAFGFVRGDITDSALVGMLMARVDQVVNFAAESHVDRSLASSAPFVRTNVVGTQVLLDAALQAGVRTFVQISTDEVYGSIAEGSWSEERPLAPNSPYSASKAAADLLALSYHRSHGLDVRVTRCSNNYGSHQYPE
>aresnopolyketides_1
VVTGASSGIGAATARALAREGFEVVLTARRVDRLEAVAKEIRNDGGTAQVFPLDVTDREAVLAFAAQFPACDVLVNNAGGAYGTEHIENADPGDWRSMYEVNVVGALHMTQALLPALKASGDGVVVVISSTA
>avilamycin_1
LVTGGAGFIGSHVVDAFLEAGAEVTVLDDLTTGDPERLDPRAVIRRVDVTDAAALDEAVRSARPDVICHLAAQIDVRVSVATPAVDARVNVEGTINVLEAAHAVGARVVFASTGGALYGEGVPVPTNEDTLPRPGAPYGTAKYCAEKYIGLFNRLHGTEHSVLRLGNVYGPRQSPGGEAGVIAIYCGLASEGGVPTVFGDGSQTRDYVYVGDVAAAFV
>avilamycin_2
VLVIGGAGFIGSQYVRELVRDGDPARVTVLDKLTYAGNLANLEPVAGRYTFVHGDICDARLLAEVVPGHDLVVNFAAESHVDRSIADAAPFIRTNVQGVQALMQVCLEAGTARIVQVSTDEVYGSIETGSWDEDAPIAPNSPYAASKAGGDMVALAYARTHGLPVSVTRCG
>avilamycin_3
LVTGGAGFIGSHVAEALLSRGHRVSVLDDLSGGTAERVPEGAHLFTGSVTDVELVDRLFAEQRFDHVFHFAAFAAEAISHSVKSLNYGTNVMGSVNLINAALRTGVSFFCFASSVAVYGHGETPMRESSIPVPADSYGNAKLTVERELETTMRTQGLPFTAFRMHNVYGE
>avilamycin_4
VVTGGAGFIGSHLCERLIERGLSVTCVDNLSTGRIANLDALADEERFTLLRADVTEPFSVEGPVHHVVHLASPASPLDYLALPLETLRVGSAGTENALRLAVAHGARFVVASTSEIYGDPAEHP
>streptomycin_1
LVTGASGMLGRELTPLLDRRGAAVTALGRGHLDITDGAAVRSAVAEHRPAVVVNCAAWTAVDEAESEPALAMAVNGEGPRHLAQACRAVGAVLLQLSTDYVFPGSGGRPYREDHPTGPRTVYGCTKRAGERAVLEVLPDTGYIVRTAWLYGAGGPNFVAKMIRLEAEQDTVLVVDDQHGQPTWTADLADRL
>streptomycin_2
LVTGAAGFIGSQYVRTLLGPGGPPDVVVTALDALTYAGNPDNLAAVRGHPRYRFERGDICDAALVDRVMAGQDQVVHLAAESHVDRSLLDASVFVRTNVHGTQTLLDAATRHGVASFVQVSTDEVYGSLEHGSWTEDEPLRPNSPYSASKASGDLL
>erythromycin_2_1
VALLGASGYVGGALLPELVPRASQVLAVSRSGVPATERVTDRRLDLATPGTIGTVVAEASVIVHAAAYGTLGSTWRDAEDPASDRVNVDLVRELVDAASRRREPPLLLFLSSAQAAAGPVSRYAEQKIEAERLVQQAGEERVLRPLILRLPTVYGVARPTGQTGRGIVAAMAHRALEGGELTLWNDGTVRRDLLHVHDTARAV
>s_layer_glycan_2_1
LITGITGQDGSYLAELLLEKGYEVYGLIRRTSTPIMVNIEHLKDKITLVSGDLTDLSSLVAIIKK
>s_layer_glycan_2_2
LITGVAGFVGKYLANHLTEQNVEVFGTSRNNEAKLPNVEMISLDIMDSQRVKKVISDIKPDYIFHLAAKSSVKDSWLNKKGTFSTNVFGTLHVLDAVRDSNLDCRILTIGSS
>alginate_3_1
LITGCSSGIGRALADAFKGAGYEVWASARKAEDVAVLTAAGFTAVQLDVNDGAALEQLSEQINQRHGGLDVLINNAG
>obafluorin_1
IVVTGAAQGIGAAITRLLLQEGADVFALDNNAQALAALADEQRSPRLHPKVVDITRPHEVEVAIAAIDNQYPLTGLVNNAGVLVAKSIATTSAEEWQTTFEVNVHGTFFVSRAVATRMAERGQGAIVTVASNAGSTPRINMGAYCSSKAAAAMLTRCIGLEFAAQGVRCNVVSPGST
>undecylprodigiosin_1
ILVTGASGFIGGHLVHRLAERGHRVRVLARSTSDRAAFAGAAAQVTVGDLGDTDSLRRATTGIRHVYNCAGLSADWGPWDRFRAVNVDGARNLVEAAHEAGTVERLVHLSTTDVYGYPERPCDERTAPRDIGLPYNRSKMLGEAAVWAAAERTGQPVTVVRPVSVYGPGSKD
>chrysomycin_1
LVTGGAGFIGSHYVRTLLSPEGPGDISVTVLDALTYAGNPANLDPVRAHPGFTFVRGDICDAPLVRSLARRADQIVHFAAESHVDRSITDPAAFTRTNVMGTQILLDAALRAGTRTFVHISTDEVYGSIDEGSWPEDHPLRPSSPYAASKASSDLLALSHHHTHGLD
>jadomycin_1
LVTGATSGIGLAVARLLASQNHRVFLGARNAENVAATVKQLQDEGLEVDGTTLDVRSGEDVKAFVQAAVD
>teichomycin_1
VLVTGSAGFIGSHLMRHLAASGRHVVGVDRRPAAAGAASGARVRHVVGDLRTLDLEPLLDGISAVVHLAAIPGVRPSWQEFDSYVECNVLATRRLLEACRATGLPRIVVASSSSVYGDSAHERMSESQAPAPASPYAVTKLAAEQLALAYAQRPGSRLSAVALRFFTVYGPGQRPDMLISRLIDAALNGTEISIYGDGSARRDFVFVDDVVRA
>myxalamid_1
ILLTGATGFLGAFLLEELCRRTDARIYCLVRSKTEQEGMNRIRKNLESYSLWNEALAPRIVPVRGDIGQPLLGLSEKEFQRLSEEIDAIYHNGALVNFLYPYESMRAANVLGTREILRLATRTRIKPLHYVSTVSVLPLGRKAPIREDEPLEGPSSLVGGYAQSKWVAEKLVREASRRGLPVTILRPGRVTGHSR
>bacillibactin_1
VVTGAAQGIGEATALALAEQGVNVAAIDTNEDLLLGLTDRLRQKGVQAQGFAADVSDSAAVNDIIAAVERDMGPIEILANVAGVLRPGPVQSLSDEDWDQTFSVNSTGVFHVSRAVSRYMIERKKGAIVTVGSNAAGVPRASMAAYAASKAAAVMFTKCLGLELAAHHIRCNIVSPGS
>spectinomycin_2_1
VVVGASGFIGSRLCRALESIGIRTIGFSREKPFAPFGSVRKELLRADTIYYVAGSSTPALAEERPELVKADHWNLQMLLWSLIKVTHRPLVVLASSGGTVYAPDAPQPFHETAPTRPSSAYGAAKLAQERALTAADWTVPVILRFSNLYGAGQRPRRGYGV
>spectinomycin_2_2
ILVTGGAGFIGSEFVRSLLLTAEPERNTPWVTVLDKLTYAGVAANLDPVAGHPRYRFVRGDICDAHLADHVMRGHDAVVHFAAESHVDRSISGAGPFVTTNVVGTQVMLDAAYRHGVGRFVQVSTDEVYGSISEGSWSEGAPLDPNSPYAASKAGADLLAHSYHRTHGMDVVVTRCSN
>lipstatin_1
ILITGATGFLGGHLADACLRSGHGVRALVRPGSNTDRLRALPGVELVTGDLTRPDSLRRAADGCEAVLHSAARVVDHGTRAQFTEANVTGTLRLMDAARAAGVRRFVFVSSPSALMHLREGDRLGIDETTPYPTRWFNDYCATKAVAEQHVLAADTAGFTTCALRPRGIWGPRDHAGFLPRLIGALHAGRLPDLSGGKHVLVSLCHVDNAVDACLRA
>lipstatin_2
ILLVGAGGTLGGAVRAALSERGHEVVGVGRTGGDLVADVTDPEAVARLYAQAGPLDAVAVAAGDA
>thiocoraline_1
VIVTGAGTGLGRAIGERLLARDANVVAVGRREAALRELTGDGGGQVATVAADITEPGAAEHVVA
>sporolide_1
VLVTGGTGFVGAHSVVALLTAGHRVRLLVRDPARVPATLRPLGIESASIDVVAGDVTDPDTVAAAVHGCTSVLHAASVYSFDTRDHPRMRAVNVRGTEVVLGAAVTAGLDPVVQVSSFGALLPARQTPVTPDAEVGTPRETYLDSKAQADRVARRYQAEGAPVVVTYPLAALGPH
>molybdenum_cofactor_1
VLVLGGAGYIGSHAADQLIEQGYDVAVVDNLGTGHRQAVPETARFYEGDIRDKAFLNHVFEQENVEGVFHFCAYSLVGESVEKPLEYFNNNVYGMQVLLEVMKAHDVNEIIFSSTAAVYGEPEIIPIQEDAPKAPTNPYGESKLMMEKMMHWCHNAYGVNYAALRYFNVAGAKEDGSIGEDHNP
>pyoverdine_1
VLVTGGTGFIGETLVNQLLDAGHTVSVLARDPLRAAYLFDGRARCLRSLSKLGHGEAFDVIINLAGAPVAGPRWSAKRQAQLLASRVGTTEALLNWLQHAQHKPELWIQASAIGFYGVRDASQSLDENAERGEGFMADLCARWESSAEPATRFGVRQVVLRLGIVFGPGGALKPLLMPFHFGFGGRMGDGRQIMSWVHRDDVLQVMARAM
>mithramycin_1
ILVTGGAGFIGSHYVRTLLGPRGVPDVTVTVLDKLTYAGTLTNLAEVSDSDRFRFVRGDICDAPLVDDLLAVHDQVVHFAAESHVDRSILGAADFVRTNVTGTQTLLDAALRQGIETFVHISTDEVYGSIDAGSWPETAPVSPNSLYSAAKASSDLVALAYHRTHGLDVRVTRCSN
>mithramycin_2
VLVTGGSSGIGAAVARAYADEGARVALTYRGGDEAAERLARELGAGRHAAMAVRYSLGEPDTVESAVATVTERWGGVDVLVANAVRWAPRRAPGTRFEEVASGDWRGFLDDNLAPTLRTVQLVVAGMRARSWGRIVLISSHVALDGHRGQEFYGAAKSALHGFARSLAWDVGRDGVLVNVVCPGLTTTER
>mithramycin_3
VVVTGGGSGIGRATARAYAAQGAHVLVVGRTAGHLEETAEGQPRIRAFVADLADRDAPERIVAAALDATGGIDVLVNNAAVPWRARLGEIDRERAE
>arenimycin_1
VLVTGGTKGIGRSITLGLAQAGARVVACYHQDEEAAAELKSIGGDHHVVRADVTRVDEVDRLADECRQRLGGLDVVVNNAGS
>arenimycin_2
LITGAHGMLGRDLAAVLAQDGEGDVVAAARADLDVTDPAGIRAAVAKADVVLNAAAWTDVDGAEAAEDAATAVNGHAVRGLAAAAGHRLIHMSTDYVFDGAATEPYPEDALPAPVNAYGRSKALGERAVLATGGYVVRTAWLYGAH
>pyralomicin_1
LVVGGSTGIGRAIAQAWSDAGAQVVVCSRTEPRDVAWEWCQVDLADPGQARERLN
>zorbamycin_1
VLVTGASGFIAGRLVERLRRDGHRVRAAGRRPAAADEFVQADLRDAEQCRRAVEGTDVVFALAANMGGIGWTHHAPAEILRDNLLITTQTVEAARAAGVTTLVYASSACIYPRYL
>desosamine_1
LVTGGAGFIGSHFVRQLLAGAYPDVPADEVIVLDSLTYAGNRANLAPVDADPRLRFVHGDIRDAGLLARELRGVDAIVHFAAESHVDRSIAGASVFTETNVQGTQTLLQCAVDAGVGRVVHVSTDEVYGSIDSGSWTESSPLEPNSPYAASKAGSDLVAR
>azinomycin_b_1
VLLTGATGFVGRFVLAELLAAGARVICLLRGGTARREELVAGMADLGLWHEEHAARLELVDGDIAEPGLGLAGPDRDRLADRAGRIIHAAAWVNHVYPYERLAAANTHCMAGLLELAARGRRSALTVVSTSSVADSAAYPPGSTVPPGPLKALPSAANGYVRSKAVAEQYLHLAAELDVPAAVIRIPSVFGDQRR
>chromomycin_1
VLVTGGAGFIGSHYVRSLLSGAYAGYERAHVTVLDRLTYAGSTANLPMTHPRLTLVRGDVCDRRPLLDLLPEHDAVVHFAAESHVDRSIHDASLFARTNVVGTQNLLDCCVRTGVRKVVHVSTDEVYGSIDEGSWTEDHPLEPNSPYAASKAGADLMARAYGRTHGLDVSVTRCSNNYGPHQHPEKLLPHFITRLLDGLQVPLYGDGRHVREWIHVDD
>chromomycin_2
VVVLGAAGYLGSAVVAELARRPVRLRRVARPGRLREIPAAVWGDASSQASPWAADLSRPGAVARAVAGADVIVHLVAHIGEASAWRAAEHDPAAARVNVEPAHDLVAALRARRGGGPPPVVLFAGSASQVGRAGVIDGSEPDEPVTVYARQKLAAEQALLAA
>chromomycin_3
LITGASSGIGTATARALAAEGARVVLTYRTGERRARELADELGADRDLACAVPYDLGDPSSVDAAVRAAENRWGGVDILVANAVRRGPRQPPGTHIEDVPAQQWRQLLRDNLEQTLRTVQLVLPGMRARTWGRVALLSSHRTRDGAPGQ
>megalomicin_1
VVLGASGFLGSAVTHALADLPVRVRLVARREVVVPSGAVADYETHRVDLTEPGALAEVVADARAVFPFAAQIRGTSGWRISEDDVVAERTNVGLVRDLIAVLSRSPHAPVVVFPGSNTQVGRVTAGRVIDGSEQDHPEGVYDRQKHTGEQLLKEATAAGAIRATSLRLPPVFGVPAA
>megalomicin_2
TLLGVSGFVGSALLREFTTHPLRLRAVARTGSRDQPPGSAGIEHLRVDLLEPGRVAQVVADTDVVVHLVAYAAGGSTWRSAATVPEAERVNAGIMRDLVAALRARPGPAPVLLFASTTQAANPAAPSRYAQHKIEAERILRQATEDGVVDGVILRLPAIYGHSGPSGQTGRGVVTAMIRRALAGEPITMWHEGSVRRNLLHVEDVATAFTAALH
>cinnamycin_b_1
ILITGARGTVARSLVRQLHDAGHRVRAGGRVPAEVDAPAGVEVVAADPTRPGDLGPALAGVEKVFVYAERSGLGGFLAAAGAAGVRHVVLLSALGASPHAADAITRAHGEAERAVLDSGLEWSFVRPGGFATNRLMWAPMTRAGGPVLDPFPESQSALVHEADVAAVALAALT
>simocyclinone_4_1
HADAVALAAGVSWASGTSAADFARERRLFRRVLDRCRASGRTLVFFSTASAGVYGADRPGREDDAVTARSAYGEHKLGMERELLDSGTDCLVLRLGHLVGPG
>simocyclinone_4_2
ILVTGIRGNVGSLVARKLVAAGLPVRGTARDLAAPGLPDGVEVVHAELTRPQTLRGVLEGVEKVFLYTVPQGIDGFVDAARAAGVRHVVLLSSIAVTWADRDRNPIARMHLGVEEPLRESGIGWTFVRPEALATNALAWAAEIRADGVVHCPFPGSYTVPVHEEDVADVAVTALT
>simocyclinone_4_3
LVTGATSGIGLAVVRTLAARGHRVFLCARSAENVKNTVEELRAEGLDVDGTTCDVRSAEDIKAFVAAAVARFGPVDVLVNNAGRSG
>glycopeptidolipid_1_1
VLISGGAGFIGSALSNRLVQAGYDVAVMDVLHPQVHARGRDIDLPPSVRLFTGDVTHAPDWDAVLRLFEPSQVVHLAAETGTAQSLSEATRHGSVNVVGTTQLLDALSRAAFVPDQLVLASSRAVYGEGA
>uncialamycin_1
VLITGGLGGLGLRIAAVLAAAGADDITLLDVTPPGALPRADAAVLGRLRARVPGLRVLTADVTDRAAVARTLAGARPVTVVHCAGRVAGAPVSDCAPGDLAALRGPKATGLSHVLAAVRHSSLRALLCFGSVTSHRAH
>capsular_polysaccharide_5_1
FVAGHNGMVGSAIVRQLKNRDDIELVLRTRQEINLLNAQDVNDFFANERIDEVYLAAAKVGGIVANNTFPADFIYENILIEANIIHAAHVNDVNKIMFLGSSCIYPKFAKQPISESELLQGTLESTNEPYAIAKIAGIKLCESYNRQHNRDYRSVMPTNLYGENDN
>calicheamicin_1
LVTGGFGFVGSHVVERLVRRGDEVVVYDLADPPPDLEHPPGAIRHVRGDVRDADGLAAAATGVDEVYHLAAVVGVDRYLSRPLDVVEINVDGTRNALRAALRAGARVVVSSTSEVYGRNPRVPWREDDDRVLGSTATDRWSYSTSKAAAEHLAFAFHRQEGLPVTVLRYFNVYGPRQRPAYVLSRTVARLLRGVPPVVY
>glycopeptidolipid_4_1
ITGASSGIGLELAELFAQRGYDLVVAAENDGIYPASDSLSRWGVDVRPVQVDLRTPEGVEKLYREATEGGRGLDAVALNAGVGGGGSFVEGELAHDLSIIDLNVRSTVHLAKLVLRNMTRRNTGKVLFTSSLASMAPGPFEAVYHASKSFVQSFAGALRDELRDTGITVTALMPGTI
>glycopeptidolipid_4_2
IAGHRGLVGSALLRRFQAEGFTNLLLRSHNELDLTDRAKTFDFVMEARPQIVIDAAARVGGIMANNTYPVDFLSENLQMQVNLLDAAVAARVPRLLFLGSSCIYPKFAPQPIKESALLTGALESTNDAYAIAKIAGILQVQAVRRQYGLAWISAMPTNLYGPNDNFSEAGSHLLPALIRRYEEARCSGRSEVTNWGTGSPRRELLHVDDLASACLYLLE
>hitachimycin_1
VVTGANSGIGLPTALELALRGAHVFVACRSPERGNAAVAQIRSRASSTRVEYVPLDLADLSSVRDLAK
>hitachimycin_2
VLITGGTGGVGAHVARHFARAGAEHLVLTSRRGSAAPGMAELSTELEALGALVTIAACDVTDRAALRALLDSIPDELPLTAVVHAAGASGRDTTLAESTLAEFAEVG
>polysaccharide_b_1
LITGGTGSFGNAVLKRFLDSDIKEVRIFSRDEKKQDDMRHRLQNKKVKFYIGDVRDKRSVDGVMNGVDYIFHAAALKQVPSCEFFPVQAVRTNVLGTENVLDSAIEHGVKNVVVLST
>tiacumicin_1
VLITGGTGAIGAAVARWVAQRGADHVVLLSRRGPDAPGAVELAQELREHGPEVTVLACDVADRQQVTDALRTVGAVTAVFHAAGV
>tiacumicin_2
VLITGGTGTLGGLLARHLVDVYGVTDLVLVSRRGLAAGRLGEELPQARIVACDVSDREALKALLDECRPSAVIHAAGVLDDATVANLTESQLEAV
>tiacumicin_3
VLITGGTGTLGGLLARHLVDAYGVTDLVLVSRRGPAAGRLGEELPQARIVACDVSDREALKALLEECRPSAVIHAAGVLDDATVANLTESQLEAVFRAKAVAAQHLHELTDGLSAFVLFSSAS
>tiacumicin_4
VVITGGTGTLGGLLARHLVDAYGVSELVLVSRRGPDAPAAGRLGEELPQARIVACDVSDREALKALLEECRPSAVIHAAGVLDDATVANLTESQLEAVFSAKAVAAQHLHELTDGLSAFVLFSSASA
>tiacumicin_5
VLITGGTGTLGRLLARHLVDAYGVTDLVLVSRRGPDAARLGVDLPQARVVACDVSDREALRALLAEFRPSAVIHAAGVLEDATVANLTEAQLEAVFR
>kirromycin_1
ILVTGAGGSIGSELVRQLWQLSPASIHLVDHDESALHAIQLDLHGHGLLDDDTVVLGDIRQADAMRELMARVRPHIVFHAAAHKHLPLLQRYPAQGVLSNVIGTANVVRAAAEAGVDRFIFVSTD
>kirromycin_2
LITGGAGGLGRALAASFTAQGATVVLAGRTPSKQVPNAEFVRADVTMAADVRALVDGVVARHGRLDGVVHAAGVLRDGLLAGKSPEDLSAVLAPKVRGTLLLHDATRHLGLDFFVA
>kirromycin_3
LVTGGSGGLAGPVVRHLVARHGFTDVLLVSRSGRVPTGLRDLSARIEPVACDVGDRDALAALLADRTISMVVHAAGVLDDGVVTALDADRLETVWRAKAAGAHHLHELLPEAELVLFSSAAGVLGG
>o_antigen_7_1
IFVTGGAGYIGSHTILELLNNGHDVVSIDNFVNSSIESLKRVEQITNKKIISYQGDIRDKNLLDEIFSRHHIDAVIHFASLKSVGESKLKPLEYYSNNVGGTLVLLECMKRYNINKMIFSSSATVYGNNS
>griseorhondin_1
VLVTGASRGIGRATALAYAAEGARVAITYHSDEAGAKETAERVAAAGGTPHVVRYDLGDEDSVRSAVASVGAEWGGVDVLVAGAVEWGEAIPRPGRKMPAFEEVPPAQWQRVLRTSVDGVFHTVQAVLPLMRDREWGRIVVLGAGLAETGLPGASAYGAAKAAL
>didemnin_1
LVTGGHGGLGRALIRHLLDRGVASVTVIGRHMATADDPRVHALSLDLAAADAGARLAVLGRFDGIAHLAGLYRERPAAEEDGRAVAELAAPKTGMLPALARLLRDDGLLIAFSSVVAHLPAAGTAAYAAANAALEA
>oligomycin_1
VVVTGATGGIGTEIVRHLATAHGVRHLLLLSRRGPDDPRAAELGRVLAEAGADATFTACDTADRAALADALADVPAEHPVTAVVHIAGVVDDGVLTTLTPDRIDTVLRPKAEAAQHLHELTADLGLSHFVLFSSGVGTFGGAGQANYAAANAFLDALAHR
>oligomycin_2
VLVTGATGGLGTLVAGHLAERHGVRHLLLLSRRGPEAEGAEELVGRLEKLGATVTLVACDAADREALAAVLAGIPAAHPLTAVVHCAGTAENALLAALTPELIDRVFRAKVDAAVHLHELTEGLDLSAFVLFSSIAGTLGG
>marineosin_1
VLVTGASGFIGGHLTRRLAELGHRVRVLVRPGSDRSGFGDAADEIETGDLDDPDSLCRAAKGVTHIYNCAGMSADWGPWEDFQRANVHGARQLVEAAHQAGTVARVLHVSTTDVYGYPKQPCDEAAGCKDIGLPYNRSKLLGERAVRNAAAETGVPVTIVRPVSVYGPRSKDFVI
>o_antigen_6_1
AIIGGSGFIGTRLATQLKNNNVEFTIVDKRNSETFPECWQYGDVTKPESLEEPLKGADVIINLAAEHKDNVHPISLYYDVNVQGAKNVCDVAEKLNIQHIVFTSSVAVYGFVEKETGEDGKYNPFNDYGKSKLEAEFAYDAWQAKVPERTLVTVRPTVVFGENNRGNVYN
>o_antigen_6_2
ILVTGGAGYIGSHTVLALLSRGDEVVVLDNFVNASVQALARVEQICDRQPHLYRGDVRDRALLQQIFAQHVISDVIHFAGLKAVGESVEKPLEYYDNNVSGTLVLLEEMRRAGVQGFIFSSSATVYGDPESVPLTESSRTGGTTNPYGTSKLMVEQILQD
>o_antigen_10_1
ILVTGGAGYIGSHTVLMLLKEQYEVIVLDNFHNSSVESLHRVKEITGSDICIINGDIRDRVILKSIFTENSITDVIHFAGLKSVSDSIQFPTEYYDNNVYGTLVLIEEMISNNIKNLIFSSSATVYGTPEKIPVKETFPVGGTTNPYGTSKLMVEKILHDVSLAYPFFRTTILRYF
>o_antigen_5_1
ILVTGANGQVGWELARSLAVLGQVVPLTREQADLGRPETLARIVEDAKPDVVVNAAAYTAVDAAETDGAAANVINGEAVGVLAAATKRVGGLFVHYSTDYVFDGTKPSPYIETDPTCPVNAYGASKLLGELAVAETGGDWLTFRTTWVFAARGK
>o_antigen_5_2
ILVTGGAGFIGCAISERLAARASRYVVMDNLHPQIHASAVRPGALHEKAELVVADVTDAGAWDALLSDFQPEIIIHLAAETGTGQSLTEASRHALVNVVGTTRLTDALVKHGIVVEHILLTSSRAVYGEGAWQKDD
>o_antigen_5_3
VIVTGANGFVGRALCRALLAAGHEVTGLVRRRGVCAEGVSEWVHEADDFDGVADRWPAGLQVDAVVHLAARVHMMRDRSPDPDAAFRASNVAATMRVARAAQQQGARRFVFLSSVKAIAESDGGTPLCENSTPAPQDAYGRSKLEAERALEQLRDELSFDTVIVRPPLVYGPGVRANFLSLMRAVSRGVPLPLGAVRARRSMVYVDNLADAVMRCVT
>o_antigen_2_1
ILVTGANGQVGWELARSLAVLGQVVPLTREQADLGRPETLARIVEDAKPDVVVNAAAYTAVDAAETDGAAANVINGEAVGVLAAATKRVGGLFVHYSTDYVFDGTKPSPYIETDPTCPVNAYGASKLLGELAVAETGGDWLTFRTTWVFAARGK
>o_antigen_2_2
ILVTGGAGFIGCAISERLAARASRYVVMDNLHPQIHASAVRPGALHEKAELVVADVTDAGAWDALLSDFQPEIIIHLAAETGTGQSLTEASRHALVNVVGTTRLTDALVKHGIVVEHILLTSSRAVYGEGAWQKDD
>o_antigen_2_3
VIVTGANGFVGRALCRALLAAGHEVTGLVRRRGVCAEGVSEWVHEADDFDGVADRWPAGLQVDAVVHLAARVHMMRDRSPDPDAAFRASNVAATMRVARAAQQQGARRFVFLSSVKAIAESDGGTPLCENSTPAPQDAYGRSKLEAERALEQLRDELSFDTVIVRPPLVYGPGVRANFLSLMRAVSRGVPLPLGAVRARRSMVYVDNLADAVMRCVT
>o_antigen_2_4
ILVTGGAGYIGSHTAVELLAHGYDVVIADNLVNSKREAIARIEKITGKTPAFHETDVSDERALARIFDAHPITAAIHFAALKAVGESVAKPIEYYRNNLDSLLSLLRVMRERAVKRIVFSSSATVYGVPERSPIDETFPLSATNPYGQTKLMAEQILRD
>o_antigen_3_1
VIVTGGAGFIGCALSGQLKAFGLPVVAIDNLHPQIHAESKRPEVLDEAAHLHIGDVTEENTWGQVLENWQPTIVVHLAAETGTGQSLTEATRHAHVNVVGTTAMLDAFSARKLVPEHVLLASSRAVYGEGAWLDANGTTFYPPPR
>oviedomycin_1
ILVTGATGNVGRNLVRELLEAGARVRALTRDPRRAGLPDGVDVAQGDLTDAESLASALRGVERAFLFPVHGRLGAFLDAATRAGLKQVVLLSSQSVVDEHLSRERMGRLNAADEQAVIASGVPWTFLRPGPFMVNDLPWAWGVKAEGVVRAAYGDAATAPVDERDIAAVAARALL
>oviedomycin_2
LVTGATSGIGLAVARLLAEQGHRVFLGARSAENVAATVKELQS
>halstoctacosanolide_1
VLVTGGTGSLGQAVAAHLADQGVSRLLLLSRRGPDAPGAGELVERLNAAGAAVEIVACDVADREALAGVLAGIPPEHPLCAVVHTAGVVSDATIPSLTPGQVAAVFAAKGDAAWHLHELTAETPLSAFVLFSSASGTIGNAGQGNYAAANAFLDAL
>auricin_1
LVTGGAGFIGSHFVRTLLDGGYPGHEEDRVTVLDKLTYAGNRENLPAAHPRLDFVRGDVCDEALLRSLLPGHDAVVHFAAESHVDRSVHSAAEFVRTNVGGTQTLLDACLATGVGRVVHVSTDEVYGSIDEGAWTEERPLLPNSPYAASKASSDLIARAYWRTHGLDVSITRCSNNYGPHQHPEKLIP
>simocyclinone_1
VALAAGVSWASGTSAADFQREVDLLHRVMDDCRASGRTLIFFSTASAGVYGPDRPGREDEPVEPRSSYGAHKLGMEQAVRESGVDHLVLRLGHLIGPGQPAHQMLPTLLRALRGGQVTVQRAATRD
>simocyclinone_2
ILVTGARGSIGSRVAGKLVERGLPVRGGVRDLAAPGLPEGVEAVQADLTRPETLARALEGVDKVFLYTVPEGIAGFVDEARAAGVRHVVLLSSIAVTWPDADRDPIGRMHLAVERPIEESGLGWTFVRPEALATNALGWAPEIRGGDMVRCAYPGAYTTPVHEEDIADVVVAALT
>simocyclinone_3
LVTGATSGIGLAVVRALAAQGHQVFFCARNAEKVAVTIKELRGEGLDVDGTSCDVRSVADVKAFVAAAVERFGPVDVLVNNAGR
>o_antigen_8_1
VLLIGASGFVGTRLLETAVDDFNIKNLDKQQSHFYPEITHIGDVRDQQILDQTLVGFDTVVLLAAEHRDDVSPTSLYYDVNVQGTRNVLAAMEKNGVKNIIFTSSVAVYGLNKKNPDETHPHDPFNHYGKSKWQAEEVLREWHAKAPNERSLTIIRPTVIFGERNRGNVY
>glivocarcin_1
VAVLGASGPTGRQVTALACAAGHDVVAVVRRPGSVTPGERLTVETADVTDVADMTSVFKGADAVLSCLGAPYSWRPVTVYSASARAVVDGMRAADVRRLVVVSAGLTHPVTRGGVRWQRPVYGILRNGPGRTLYADMRRMEDILTGARDLEWTVMRPARLSDEARPGDELRVTADLPGGRAWTTRRDLAIAMLDELT
>glivocarcin_2
ILVTGGAGFIGSHYVRTLLGPHGPAGVRITVLDKLTYAGNPANLDPVRAHPGFRLVQGDVCDAAVVDRLVAEHDQIVHFAAESHVDRSILGGAEFVRTNVGGTQVLLDAALRHHGRGRGVFVQVSTDEVYGSIPYGSWPETHPLSPSSPYAASKAAADLVALAHHRTHGLDVRVTRC
>glivocarcin_3
LVTGGSSGIGKSVARRLASAGHTVTICGRDSERLQQAAK
>benastatin_1
LVTGGSRGIGKAIVLALARAGADVLACHQNPSAQADQLALELKRTEGDHHLLQADITDPADVDRLVNEA
>bleomycin_1
VVTGAGGFIGSHLVRRLVRDGHRVRGVDLVPPRYGPGEAQEFVIADLRDAAQAARAVAGADSVFALAANMGGIGWTHTAPAEILHDNLLISTHTIEACRAAGVRTTVYTSSACVYPASLQREPDAAPLAEDPVFPA
>pladienolide_1
VLITGATGGLGPLLARHLVVEHGVRHLLLTSRRGAAASGAQALLDELADLGAEATVVSCDLADREAVAGLLAQVPPARPLTAVVHAAGVLDDGVIPSLSPERVDGVLRPKADGALHLHELTKDLDLAHFILFSSTAGVLGSAGQGNYAAANTFLDALAQHRRAA
>PM100117_1
VLITGGTGALGARVARWVAERGASRVVLTSRRGPEAPGAPELEAELSALGVGVTVAACDVADPDAVEALLSEHPVDAVFHAAAVLDDGVLDSLTPERFAAVLRAKAVSAANLHEATRGHDLSAFVLFSSFAGAIGAAGQANYAAANAYVDALAERRAAEG
>xantholipin_1
LVTGGNRGLGLAVASRLHAEGHRVVVAAREEETARKTAEMLGGSATGVALDITDAASVAHAVKATGPVDILVNNAGVQLDWGKAPSAIELELVERTLQVNLLGSWRVAQAYVPLMVRAGWGRVVNVSSG
>xantholipin_2
LVTGGTRGVGRGIVKALANAGVDVLTCYQNSSDAVTSLEKELKETGGNHHVVRADVSDPDDVAALLAQA
>vpe_1
LVTGGTGFLGTHLVPRLVAAGHEVRLIGRSRPSGAPYAGTEYVPGDLKNRDAVRRALEGVDAVYHLAGLVSFQPKDARKMFELHVDSTRELLRDVREAGVKRVVLASTSGTIAVSKEAHVRDESADYPITVVGQWPYYLSKIYEEKLALAYCRKHEIPLVVLNPSLLMGPGDDRLSSTWTVVKFLNREIPAMPGGGISFVDARDAADAFVQALT
>vpe_2
LITGAGGFLGMWLAKALAARGDSVTCLLRPGGDASGLAGLTYTRVEGDVTVPSTLSAAVAGQDVVFHLAGARRGATRDDFMRVNAEGTRHLCEAMVAAGHRPRLVLTGSLAACGPSTPTRPHVEEDAFHPHEWYGESKAEAERIAFSYGDRLPVTVSRPPRILGPGDRENLPFFKMAQRGIRLELSGGPRPLTMVDVEDVVDILL
>bacillibactin_2_1
ITGAAQGIGEAVARTLASQGAHIAAVDYNPEKLEKVVSSLKAEGRHAEAFPADVRDSAAIDEITARIEREMGPIDILVNVAGVLRPGLIHSLSDEEWEATFSVNSTGVFNASRSVSKYMMDRRSGSIVTVGSNAAGVPRTSMAAYASSKAAAVMFTKCLGLELAEYNIRCNIVSPGS
>equibactin_1
IGVLGCNGNIGSLFMEKVSKWEDNYIYAVSRSHMNFIKKDNIEYIFFDAENIEKLDKFCSKCDVIVNCTG
>polyoxin_1
VVVSGASSGFGRVTARRLAAQGHTVIAVARRADRLAELADGEGPGRVLPAVADVTDLDALERALDEHLPHCPPVVGLVNNAGLSSGFGPVQSAKVDDWRRMVDTNVSGLLHTTTLLLPRLIAGGRGHIVNIGSIAARYPYAGGNVYAATKAFVHQLSLSMRTDLEGTGVRVSCVAPGMARTEFALVRYDGDQERADRLYDGVSPLSPDDVADAVLWCL
>nanchangmycin_1
VLVLGGSGYLGRHICSAFGAAGAQVVPVSRGARGGVDGDGCRSVRLDLTAAGPDELARLCAGTGARVLVNASGAVWGGGERQMAEANTELVGRLAGAVARLPGRPRLIHLGSAYEYGPARPGTAIAEDWPPAPTTVYGRTKLSGSQAVLRAAAELGVAGTVLRVSVACGPGAPVSSLAGAVAAHLAAGRDELRLAPLRDHRDLVDVRDVADAVVAAA
>nanchangmycin_2
LVTGAAGFIGSTYARRLLARGGAEWGPDVSHVTVLDKLTYAGTLSNLDTADPRLTFVHGDICDADLVDTLMARANQVVHFAAESHVDRSITGADPFVRTNVEGTHTLLQAALRHGVERFVHVSTDEVYGSVETGFSPETAVLDPNSPYAASKAASDLIALAYHRTHGLDVRVTRCSN
>nanchangmycin_3
VLITGGTGGVGALLARWAAERGAAQLVLTSRRGPNAPGAAELAAELRGLGVAVTIAACDAADPEAMRGVLDAIPAEHPLSAVIHAAGVSEQDLIADVDDEHLNRMLAPKALAA
>phoslactomycin_b_1
VVVLGVTTGLGGRLASSLLAGGDTPVGLVLRDSDGERMRAARIEPFVLDTDGSDLDVQLKRAFRGTDAVVLAAGTGTGPGSLGAAVSSPAAQLCAAVEDCGVRRFVMVSAHLPGARDRAALGDQLDAYLAEKRAAEQVVREQDLDWCVLRPGMLTDDPPLGTVRARPDGVPTAGDELSRSDCAEAIRTV
>avermectin_1
GGAGFIGSHFVRRLLTGAYPAFTGAEVVVLDKLTYAGRLENLAPVLGSPSLIFVHGDICDGPLVADLMDGSDMVVHFAAESHVDRSVADAAEFVRTNVLGTHTLLRAATDAAVDRFVYISTDEVYGSIDSGSWTEDAPLEPNSPYSASKASSDLLARSFHRTHGLPVIITRCS
>avermectin_2
VVVLGASGYIGSAVAAELARWPVLLRLVARRPGVVPPGGAAETETRTADLTAASEVALAVTDADVVIHLVARLTQGAAWRAAESDPVAERVNVGVMHDVVAALRSGRRAGPPPVVVFAGSVYQVGRPGRVDGSEPDEPVTAYARQKLDAERTLKSATVEGVLRGISLRLPTVYGAGPGPQGNGVVQAMVLRALADEALTVWNGSVVERDLVHVEDVAQAFVSCL
>lankamycin_1
LVTGAAGFIGSTYVRNVLAGAYGEAGEVRITALDKLTYAGNPANLAEVRGHPDLTFVQGDICDTELLADLVPGHDAVVNFAAESHVDRSIAGADDFVRTNVLGTQALLSAARAARVPRFVHISTDEVYGSIESGSWTEDCALLANSPYAASKAGADILARAYARTYGMDVSVTRCSNNYGP
>lankamycin_2
IVVLGASGYIGSAVVRELACRPVRLRAVARGPFTVPAGGRAETAVMRTDLTAPDAVAEAVRGADAVIHLVARMTGRGSWRSAASDPQTERVNVDLVREVVERCAAPSGGRPAPTVVLASTNQVTDGGPPRSAYARQKAAAERHLLDAALRGTVRGIALRLPTTVGSEAGVAPAMAGRALAGEALTLWHDAAVRREFLDVTDAARALVTALD
>lysolipin_1
LVTGANRGIGRATAAALHALGWRVVLAARDADEAERAAASLGPGASGIALDVTCPRSVARAAGRAGEVDALVNNAGVLLDAGADPLSVPIEVVRATLEVNVLGAWRVCRQFVPGMVRRGWGRVVFVSSG
>lysolipin_2
ITVFGATGNVGREVVSLLTAAGGPVRAVTRDPSRAGFGAGIEVVRGDPGRPGDARRALAGADAAFVVTAGPDAPAHALAIAQAVRRCGTGRVVTVSSVAAMEPVTNAYGAAHAEAERAFRDCGAAWTLLRPAAFMSNTLQWLWSLGSEGRVYQPYGELPQAVVDPADVAEVAVRALT
>kiamycin_1
LISGAGRGIGAATAREFGRRGCHVIVNYLSNSEAAAVVVKDITSAGGTAQAVRADVCDAGQVGTLVDGVLAEHGRVDVLVCNANTAAPPYGPFASLPWESFAAKLTGELAGVYFLTQRVLAAMREQRAGRIVYVSSTAADVITGSIAHSTATAALNTFSRQIAAEAAQY
>kiamycin_2
LITGANKGLGYETARRLTEAGHTVLLGARDPRRGRAAAERIGARFLPLDVTGEESVLAAADRVREEFGHLDVLVNNAGITGPRKEAAELTADDIKKLYDTNVFGAVRVTRAFLPLLRAGESPTVVNV
>kiamycin_3
LVTGANKGIGRAVVRRLGELGQRVYLGARDVERGRNAERELRAEGLDVRFVQLDVTDESSVALAAKRIEEETGHLDALVNNAGTGAPVRAPSRTPASVVRRTYETNVFGVITVINTMLPLLRRSRAARIVNVSSVVGSLTHAAALDDP
>aldgamycin_1
VLVTGALGFIGSHFVRQLDARGAEVLALYRTERPEVQAELAALSRVRLVRTELRDESDVRGAFKYLAPSIDTVVHCAAMDGNAQFKLERSAEILDSNQRTISNLLNCVRDFGVGEVVVMSSSELYSASPTVAAREEDDFRRSMRYTDNGYVLSKTYGEILARLHREQFGTNVFLVRPGNVYGPGDGFDRSRGRVIPSMLAKADAGEEIEIWGDGSQTRSFVHVADLVRASLRLLE
>aldgamycin_2
VLVTGAAGFIGSHFVRQLLSGSYPELADAHVLSLDKLTYAGNTENLAEVAGHPRHTFLHGDICDRPTVTQALRGIDLVVHFAAESHVDRSITDSAAFITTNVLGTHTLLRSALEAGVSRFVHVSTDEVYGSIPEGSSAETDPLDPNSPYAASKASSDLLALAFHRTHGLDVRVTRCSNNYGPHQHPEK
>thiotetroamide_1
VVITGGTGTIGRALARHLVTRKSVRSVALLSRSGRQAPGVTALTSDLERLG
>thiotetroamide_2
LITGASSGFGRAIAEAALAAGDVVVGAARRPEALDDLVAAHPDRVEALRLDVADTGAAEAAVRDVVARHGRIDVLVNNAGRTHVGAFEETTEEELRALFEVHVFGPAALTRAVLPYMRERRSGAIVQMSSMGGQLSFAGFSAYSATKFALEGMSEGLADEVAEFGVKVLIVEPGAFRTGLFATGRAG
>FD_594_1
LVTGASSGIGQSLARCLAAQGTGVVVVARRGDRLERLAEELRGRYEASVEVLAADLCVPEDLAGVTKRLTDPDRPIDLLVNNAGAGSRPPRPLADQPLDHELGKVELNVLAPLRLTHAALSVMIPRRHGGILNVSSIAGFLPQPQGATYAATKAFLTSMTETVYCEARKSGVHATVVCPGFVRRGEGGADGGMRSLRLPEFAWLDRDEVAREAIRA
>FD_594_2
VLVTGAAGFIGANFVHYWRAAHPGDTVVALDALTYAGNEENLATVRDGIVFVHADIADGARMSRVLREHRVEVVVNFAAESHNSLAVLDPARFFRTNVLGTQALLEASLRAGVERFHHISTCEVYGDLALDSPDAFREDRAYRPRTPYNASKAGADHAVR
>hygromycin_b_1
LVTGGAGYIGSVVARRLLDEGHRVVVVDDLSSGFADAVPEGAQFVRGDMAVAARILAGPDRFDGVVHLAARSLIDDSVRRPERYWRGNTQQSLVLLDGMLAAGVGRIVFSSTAATYGQPERVPIPEDAPTRPTNPYGASKLAVDVALADYARAHGLAAVSLRYFNVAGAVGRHGERHEPETHLLPLALAAALGRGPELRLNGDDYPTRDGTCVRDFIHVADVADAHLAAL
>hygromycin_b_2
LVTGGSGFIGRHVARRFHEGGHEVLVLDTRWTPGDPFPGEATSVTDERRLRELFADWRPDVVAHLAGMADARAVLAEPVAAMDANVTGTAAVLAAAAASGVSRVVIAGSCWVYNAMPVNAVDEDEPFLPSGAGHFYTTTMIAKELLARDFARLHGLESTVLRYSPVYGPGMWPGLVVSAFLRAAAAGGPLTVFGDGEERRAFLHVHDLAEAFYRA
>doxorubicin_1
VIVTGGGSGIGRAVARAFAARGDRVLVVGRTAGPLAETVDGHKDAHTLAVDITDPAAPEAVVREVRERLGGVVDVLVNNAATAAFGHLGELHRTAVE
>doxorubicin_2
LVTGGTSGIGLAVVRKLAQDGTRVFLCARDESAITGTVKELQASGLEVDGAPCDVRSTADVDRLVQTARNRFGPIDIVVNNAGRGGGGVTAEITDDLWLDVVDTNLSGAFRVTRAVLTGGAMQEHGWGRIISIASTG
>o_and_k_antigen_1
FVAGHKGMVGSAIVRQLSKDSSVEVITKDRNELNLLDALAVEAFFVTHNIDQVYLAAAKVGGIVANNTYPAEFIYQNLTIQNNIIHSAHLHGVQDLLFLGSSCIYPKFAQQPMREDSLLTGILEETNEPYAIAKIAGIKMCESYNRQYGRNYRSVMPTNLYGENDN
>spinosad_1
VLVTGGTGGLGAHVARWLADAGAEHVAMVSRRGEQAPSAEKLRTELEDLGTRVSIVSCDVTDREALAEVLKALPAENPLTAVVHAAGVIETGDAAAMSLADFDHVLSAKVAGAANLDALLADVELDAFVLFSSVSGVWGAGGHGAYAAANAYLDALAEQRRSRGLVATAVAWGPW
>coelibactin_1
IGVLGASGAVGRAAVRELRALGHTGLRLGGRTVSTLRAVAEEGPAGHDETVWADADAPDGLRAFTEGCDIVLNCVGPTYRLRATVASAALAAAA
>salinilactam_1
VLVTGGTGGVGEHVTEWLLAGGADRVVLASRRGLDAPGAADLVARHRGVDVVVCDVADRDAVAALLADLGDDLTAVFHAAGVLRPEVPLGETGLDDFADVCRA
>salinilactam_2
VLVTGGTGGVGEHVTEWLLAGGADRVVLASRRGLDAPGAADLVARHRGVDVVVCDVADRDAVAALLADLGDDLTAVFHAAGVLRPEVPLGETGLDDFADVCRA
>salinilactam_3
VLVTGGTGGIGTHLSEWLLDQGADRVVLASRRGPAALGAADLAARLPAVQVVACDVTDRDAVATLLDGIGDDLTAVFHAAGVLRDAAPLDETDLDAFADVCRA
>A201A_2_1
LVTGAGGFIGHHLVSYLRRQGYWVRGADLRHPEFRPTEADEFVLADLREPGVAEKVVEGVDEVYSLAADMGGMGFISANHATIMKNNSLIDLNTLEAARKARVNRFFYASSACVYP
>A201A_2_2
LVTGASGAIGTAIATALAAAGFDLGVHHHTDAAGGRRTAAAAAALGARAVPVQGDLAREKACVAAVERVVESFGRLDVLVANAGRHRDALLLRLSEDDWDRHQEANLKSAYLCVRAALPSMLRQRHGRIVLVSSVAGLVGSPGQAAYSAAKAGLAGLARTVAHEHGRYGVTCNCVAPGLIADTPSHDGLSEARRRQILDRTAAQRAGRPEEVAAAVA
>phosphonoglycans_2_1
IFLIGAAGGIGRRLSPLLAHRGDEITGIHRDSAQTETVESSGATSLLGDLIADSTDELATKMRGHDAVVFSAGAHGTGQELTTLIDGIGLEKAAEAAAQASVPRFVLVSVFPDAGRDRERREGFEHYMKVKKTADVYLTRTDLDWLIVRPGTLRDEPGTGKVTAGPAIEYGDVPRDDVAAFIDAA
>AWQC131C_1
IITGASSGIGAATAFALAAEGAKVAIAARRAECLDVLAKQIAASGGQALSIVTDITNEAQVNNLVQKTNGELGHVDILVNNAGIGVFGTIDTGNPADWRRAFDVNVLGVLYAIHAVLPLLKAQKSGHIVNISSVDGRIAQAGAGVYSATKSGVNALSEALRQEVYKDNIRVTIIEPGLVDTPFIDLISDPIIKQLSEEQRQTITPLQSEDIARAIIYAVT
>tunicamycin_1
ILITGGAGFIGGHLARALVASGEEVTVLDDLRVPPMIPPEGTGKFLEKPVLELEERDLSDVRLVYHLASHKSVPRSFKQPLDYLDNVDSGRHLLALCTSVGVPKVVVGSTCEVYGQADTLPTPEDSPLSPRSPYAASKVGLEMVAGAHQRASVAPEVGIVRFFNVYGPGERPDAL
>tunicamycin_2
VLVTGGAGYVGSFTVRRLLAAGHEVVVVDNLSTGRREAVRGCRLHVVDILDIASMGTVFEEFHPEAVIHFAALKSSEESLRDINTYFSVNLTGTQNVLALCARTGVERFVFSSSCAVYGTPQI
>lobophorin_1
VAVTGGAGFIGSHYVRQILSGAYPEFADASVVVLDKLTYAGNEENLAPVSADRRFELVVGDVCDAGLLADVLPGVDVVVHFAAESHVDRSITGPADFMHTNVQGTHTVLNACLDAGVRRVVQVSTDEVYGSIDAGSWTEDHPLEPNSPYSASKASADLVARS
>butirosin_2_1
VFITGANRGLGLSLCEVFLERGHQVLAGVRNMNRAGQLLPLKTKYKEELSIIPVDVSSQDSIRQAYSLITAVTPKLDAIINNAAREGIRCKKIQEVDIADFEETWKTNVLGPMAIIKSLKPMMESSSVKSILNISSEAGSISELPLKTYGYCISKAALNMFTRMLERELKPENFKVVAVHPGWMKTE
>cyclizidine_1
ILLTGATGFLGSFLLRDLLRSTSARIHCLVRGADASDARARLTAAAAWYETGADLDFDRIDIAVGDLAEPALGLDEAAFDELARNVDVVYHAGASVNWLYPYEALRPANIAGTEEVLRLAARHRTVPVHYISSTGVYAQEPAEGRRIAVDDPIGPPELLSN
>streptolydigin_1
VLVLGGSGFLGRHLTAAFHRAGWQVTAVSRSGEAGQPAGGPEPAARMLALDVPGADPGTLTEVLTRTAPHVVVNAAGAVWAASEEEMARGNVLLVDRLLTVLPRLPRPPRLLQLGTVHEYGPPLGDGPVTEAAALRPVSGYGRTKARASEAVLGAARDGALEATVLRISNAVGAGLPPASLLGGVAAALAAAPGDGAPAVLRLGPLTARRDFVDATDVAEAVVAAAA
>streptolydigin_2
ILVTGGAGFIGSHYVRTLLGTPGAADCGRLTVLDKLTYAGNTANLATVWDDPRFTFVRGDVCDAGLVDKLVADHDTVVHFAAESHVDRSIAGASDFIMSNVVGTQTLLDAALHHQDSFGTFVLISTDEVYGSIDTGSWTESHPVAPNSPYAAAKASSDLITLAYGRTHGLDVRVTRCS
>validamycin_2_1
ILILGSGYLAGHIAARLTRLGAETVLSSRRAPVLPESRGVRWKQVDVTSGPQVAALMDAVEPDAVVAVHGPSDITWCESHPEEAYATHHGGARNIAAALDGRPVLLVSTDNVFSGEDESYGESAQTFPVNAYGRAKLAAERELLDTSSALVLRVSLVYGWE
>steffimycin_1
VIVTGGGTGIGRATARAFADRQDRVLVVGRSASTLTETARGYPNIHTLPVDITEPGAAETIVRAALREFGRIDVLVNNASTAVPAPLENIAPAEVDRLLAVNLRAPIALTREALDALTRTRGTVVNLSSAGSLGR
>kasugamycin_1
VLVTGADGFIGSHLTETLVSRGARVTAVVRRVSAAQVTHRLRNLSAATVDALERVVHVDLAGPSAVDVLGRLEADTWFHLAADAYVPASLDQPADVVRTNVMSTLHVLLAAQQRQPAHLLVTSSSEVYGSQPDAITERHPLEPATPYAASKVACDRLAWSWHHTYGLPLTIVRPFN
>chloramphenicol_1
MITGTRTGIGKALAEHFLEAGHDVVGCSRRPPTIDHPRYRHHEADLADPGQTKRMFRSVRA
>ansamitocin_1
VVVVGASSGIGRVTALRFAAAGARVVCAARNTRALDGLVEEVRGAGGRAVAVTADIADEAAVRAVADVAVERFGRVDTWVNAAGIGVYGRVEDTPAGEFDRVMRVNYLGHVHGAKAALPALRRAGGGVLIGVASVLGLRSAPLQAPYAASKAAVRAFYDALRVELAHDGESIAVTAVLPAAINSPFFEHCRSRVGSLPKPPPPVYAPELVAEAVLRAA
>malleilactone_1
LVTGAAGGVGRALIDWLIDEQQVPPEKIVALCRDAASAPRGVRAVAVDLADERALDAALESIDEVEGIFHLAGTLDDGVIANLDDARLRRVLAPKQSLAALLAHAPRWRTRWAVAFSSTSALLGVPG
>exopolysaccharide_1
VLVVGGAGYIGSHMVKMLLGEGHDVITFDNLSSGYRDAVVGGTFVQADLADKAALDEVFVKHTPDAVMHFASYIQVGESVRHPDKYYLNNFTNTMNLLDAMVKHGVNYFIFSSTAAVFGEPEYVPIDEAHAKNPLNPYGRSKLMVEQALGDYERAYGIKSVCLRY
>desosamine_2_1
LVTGGAGFIGSHFVRQLLAGAYPDVPAGEVIVLDSLTYAGNRANLAPVEADPRLRFVHGDIRDADLLARELRGVDAVVHFAAESHVDRSIAGASVFTGTNVQGTQTLLQCALDAGVGRVVHVSTDEVYGSIDSGSWNESSPLEPNSPYAASKAGSDLVAR
>glycopeptidolipid_1
IAGHRGLVGSALVRRFEAEGFTNLIVRSRDEIDLTDRAATFDFVSETRPQVIIDAAARVGGIMANNTYPADFLSENLRIQTNLLDAAVAVRVPRLLFLGSSCIYPKYAPQPIHESALLTGPLEPTNDAYAIAKIAGILQVQAVRRQYGLAWISAMPTNLYGPGDNFSPSGSHLLPALIRRYEEAKAGGAEEVTNWGTGTPRRELLHVDDLASACLFLLE
>kiamycin_2_1
LVTGATSGIGLSVARLLGSQGHKVFIGARNADNVAETVKQLQGEGLEADGSALDVTDAASVKAFVQAAVDRFGT
>apoptolidin_1
VVVFGGTGFLGRQICQNFVAAGREVLVLGRTAPLAAAGCRFRAVDVARTPTRDLAGLLAAERPATIVNATGSKWGLTGRDLVDSCVGASRNIMAALAESAVTPRYIHLGSVLEYGYLAPPPVGPDSAYGQLKLAATETVLEAAAAGTVDAAVLRLANVVGPGAAAESLPGLVAGKLADADRRGEPALIEVTALNAHRDYVDVRDVADAVAAAA
>apoptolidin_2
VLITGGTGALGSRVARSLARDGAEHLVLTSRRGPAAAGAAGLRAELEALGAQVTIAACDVADRSALAALLDEHPEVRAVVHTAGAVSMAPLAETGLADFAEVLAA
>apoptolidin_3
VLVTGGTGALGARVARWLAGRGAEHLVLVSRRGQAAPGAAELEAELAALGVRATIVAGDVADRAAAADLLDRFPVDGIVHAAGVLDDGVVTSLTPARMNEVLRAKATAAVNLHELTRDRDLRMFALFSATSAVVGTPGLGNYAPGNAFLDALAGHRRANGLV
>lankacidin_1
LVTGGLGKVGRAITELLAERYRATVIAVGRSAPDAAQRQWIAGTPGLHYEQADVTSAARTRELVDTVRARFGGIDGVVHCAGVVRDALVQNKSAGDAEAVLAPKLRGTLNLDRCTADLPLDFFCVFSSISSVMGNTGQSDYIAANRFLDEFAAERARRVAAGERGGLSLSVNWPLWLDAEDERREQYQALAAFLRGQFGMEPLSARRGAQLFLDLVD
>burkholdac_1
LVTGGNSGMGRAIGRHLVERGARVVALSRRGGQSIPGLTAIAVDVSDLDALRRAVAQIRAEHGPINGVVHSAGMPPHALLRTAADTAMRDVLAGKFLGARNLRQVLCADSLDFVVLCSSLRAHVPAAGA
>cosmomycin_d_1
IITGGGTGIGRATARRFAGQGDRVLVVGRTAAALDETAEGHDGIRTLVADVTEPGAGEAVVEAALRAFGRVDVLVNNAGTGTFAPLAKLDRAATEHQLAVNLLAPAFVAQAALDALEATGGTIVNVSSAGSL
>cosmomycin_d_2
VAVLGATGCVGRSVCDELSRTGHRVLAVARHPAPHTRPHAFVPLDVAGTAPERLAALLDRYGVTAVVNATGGWGTTVEEMRRAHIDLLERLVDGCAATSRRLRVVQLGSIHEYGPVPDGVLIDEHREPGPLTPYGLTKRTGSEHLLAQTRAGRVDGVVLRAVNVCGPHTTTASFLGAVVARLRALGPGDELSLDVADARRDFVDVRDLARAAVAAVH
>cosmomycin_d_3
ILVTGAAGFIGSHFVRTLLSGGYPGHEDDRVTVLDKLTYAGTLNNLPAHHPRLTFVHGDICDTTLLDKVFPGHEAVVHFAAESHVDRSVAGAEAFVRTNVLGTQALLEAALRHGIGVFVQVSTDETYGSIAEGRWTEDEPLLPNSPYAASKASADLIARSYWRTHGLDVRITRCANNYGPGQHPEK
>cosmomycin_d_4
LITGASSGFGRAIAEAALAAGDVVVGAARRPEALDDLVAAHPGRVEALRLDVADTGAAAAAVRDVVARHGRIDVLVNNAGRTHVGALEETTEEELRALFEVHVFGPAALTRAVLPHMRERRSGAIVQMSSMGGQLSFAGFSAYSATKFALEGMSEGLADEVAEFGIKVLIVEPGAFRTGLFETGRAGAS
>teleocidin_b_1
ILLTGATGFLGAFLLRELLDRTSADIHCLVRAEDAAQADRRIRRNMAEYGLWNEFSRNRIVAVPGDLEKPLLGLSPERFDALAARLDAVYHNGARVSAVDPYDRLRAANVAGTREVLRLAARFATPVHHISTAAVSVGTDEHPGPVPESHRVAPEAVLPGGYTETKWVAEQLVWAAAGRGLPVTVHRCGR
>lidamycin_1
LVTGGAGFIGSQFVRATLHGELPGSEDARVTVLDKLTYSGNPANLTSVAAHPRYTFVQGDTVDPRVVDEVVAGHDVIVHFAAESHVDRSIDTATRFVTTNVLGTQTLLEAALRHGVGRFVHVSTDEVYGSIASGSWTEDTPLAPNVPYAASKAGSDLMALAWHRTRGLDVVVTRCTN
>lidamycin_2
VVTGASSGIGLHLAQELARHGAHVVLAVRDPDRGVAAAARIQSRVPSAQLTVRRLDLSRLASVRA
>WS9326_1
LVSGGSRGIGRAVVLRLAAEGYDVSFCYQSNEQAALELEKEAGELGRRALAVRVDVTDAASVRDWVTRTESELGPVDVAVSSAGITRDNPLVLMSDEDWHSVVDTNLDGVYHVCRAVIFEMMKRKSGTIINISSIAGVYGNATQANYS
>stambomycin_1
VLVTGGTGALGAHTARLLARRGVPHLVLVGRRGPDAPAADELAAELTALGSRVTLVACDVTDRAALAEVLAGIPEDLPLTGVVHAAGTVDDGVIGSLTPGRVGEVVHARLTAVRHLDELTARHDLDAFVLYTSFAGVVGN
>stambomycin_2
VLVTGGTGALGAQVARLLAARGHNRLLLVSRRGPEAPGVAELAAELAAVGTMATAVACDVADHDALAALLAGIPEQHRLTAVVHAAGVLDDGVIDGLTPERFEQVLRAKTLAAENLDALTRDLPLDAFVLFSSFTGAVGTAGQANYAAANAHLDALAERRRAQGLPATAI
>stambomycin_3
VLITGGTGALGALVARYLVDRREVDRLLLLSRRGPDAEGADTLASDLEAAGARVEIVACDVTDPEALAEVLDGRRVSSVFHLAGVLDDGVATALTPERVAPVLAPKITAARALHELLPEVEEFVLFSSVSATLGSPGQASYAAANAYLD
>stambomycin_4
LVTGGTGALGAHVARWLADRGAPHLVLAGRRGAEAPGMTDLAAELTAAGTEVTIAACDVSDRAALDELLAAHPPSAVVHAAGSGGFGTLDDASEADIATVLAAKVTGALHLDDALRDADLDAFVLFSSVSGIWGSGGQAAYGAANAALDALASRRAARGLPATCVAWGPWHGS
>stambomycin_5
VLITGGTGGIGRHLAHHMAARGARKLVLTGRRGPDAPGARELAAELTARGVETIVAACDVTDRNQVAALLAQHPADAVIHAAGVAQATALADCGESELAAVTAAKTEGARHLDELAADVGTFVLFSSGAGVWGGAGQAAYAAGNAVLDALAQDRRARGLPATAVAW
>stambomycin_6
IVVTGGAGFIGSHFVRQAVTGAYTGGTAPEVVVLDKLTYAGNRANLAPAEDYPGLTFVRGDICDPALVADVLTGCDLVVHFAAESHVDRSISGSEEFIRTNVLGTQVLLDASLRAEVQKFVHVSTDEVYGSIDEGSWSEDRPLEPNSPYSASKASSDLLVRAFHRTHGLPVCVTRCSNNYGPY
>FK520_1
VLVTGGTGGLGRLLVDHLLTVHEAAEVVVVSRNGRPGDTPEDDRVRYVAADVVDRDELAAVVADVAQRLRAVVHMAGIVDDAAVTTMRPEQWDAVLRVKADVAWHLHELTRDLDLAAFVLYSSISATF
>saxitoxin_1
IITGASSGIGEATAFALAAEGAKVAIAARRAELLHALAKRIEASGGQALPIVTDITDESQVNHLVQKTKVELGHVDILVNNAGIGVFGAIDTGNPADWRRAFDVNVLGVLYAIHAVLPLLKAQKSGHIVNISSVDGRIAQSGAVVYSAAKSGVNALSEALRQEVSLDNIRVTIIEPGLVDTPFNDLISDPITKQLSKEQLSTITPLQSEDIARAIIYAVT
>hatomarubigin_1
VVTGANKGIGREIARQLAVRGLVVYLGARSERRGREAESALRADGLDIRFLHLDVTDETSVALAAKRLEDEVGVVHALVNNAGVGGPYLPPSRTSAAQVRETYDTNVFGVITVTNALLPLLRRAGSARIVNVSSAVGSLSA
>saprolmycin_e_1
ILVTGAAGFIGSHFVRSLLADEYSGWEGAQVTALDKLTYAGNRDNLPASHERLVFVRGDVCDRALLRELLPGHDAVVHFAAESHVDRSLEGAGEFFRTNVLGTQTLLDAVLDSGVERVVHVSTDEVYGSIEEGSWTEDWPLAPNSPYAASKAGSDLVARAYWRTHGVDLSITRCSNNYGP
>saprolmycin_e_2
AHRAPADARGVAAAHLDLLTATAEEITAVLAGADVVVNAAGRAWRADEAEMTAGNAELVDRLVTALAALPGPPVRLVQLGSVHEYGAGAPDGATGEEHVPAPVTPYGRTKLLGTRAVLRGAREPGVDGVVLRLANVIGAGVPQGSLFGRVAAHLGDAARAEARGEKAAALHLPPLRTARDLVDAGDVAAAVLAAAT
>saprolmycin_e_3
AGVSWASGTSDEDFAREAALLREVAERCRDTGRRLLFFSTAATGMYGLAEGPGREDTPVTPCTPYGAHKLALEELLRDSGADHLILRLGHLVGPHQPEHQLLPT
>actinorhodin_1
VLVLGATGKQGGSAARYLLERGWTVRAFVRDPGAPKAKELRELGASLHTGDLEDAGSVRAAMKGAYGVFSIQTPMTPAGVEGEERQGKICADAARDLGVQHYVHSSVGGAERPEGVNWRLSKLAIEQRIQENALRFTFLRPSYFMENLNHDMSPLVMEDGVLTFRRGLGPANTLQMISGPDIGYFAADA
>cremimycin_1
VVVTGGTGFIGSHFVEELLARQAHVIRLYRTGSRHPSSDLPGNDRLRTIRVDLCDEPAVRRVFAWAPGGVDAVVHCAAMWGSAGYRYDHPATVFEANFRPVANVLKCAQEHGVTDVVLLGSGEIYKAPTARPLREEDDFRTAVRYTTDGYYLAKLHEE
>cremimycin_2
LVTGANSGIGLPTARELARCGARVLLACRDERKAAAAEERIRRHVPTARVESVRLDLADLASVRALADSLAARLDGLDILVNNAG
>cremimycin_3
VVVTGATGTLGRAVARHLVTAHGVRDLLLLSRRGAQAREAAELVDDLTGLGASATVRACDVSDRDALAEALAGVRVSGVVHAAGVVDDGVLPSLTPERVHAVLAAKADAARNLHELTADMDVSMFVLFSSAAATLGTAGQAAYAA
>cremimycin_4
TGGAGFIGSHYVRTLLAGGYAGYEDAEITVFDALTYAGNRGSLPVSHPRMRFVQGDVCDRAALLDLLPGHDVVVHFAAESHVDRSIHAPVEFVRTNVLGTANLLDACVRTGVPRVLHVSTDEVYGSIAEGAWTEDWPLAPNSPYSASKAGADLVARAYWHTHGLDVRVTRCCNNYGP
>chalcomycin_1
VLVTGAAGFIGSHFVRQLLSGSYPELAGAHVLSLDKLTYAGNTENLAEVAGHPRHTFLHGDICDPPTVAQALRGTDLVVHFAAESHVDRSITDSAAFVTTNVLGTQTLLRSALEAGVSRFVHVSTDEVYGSIPEGSSTEADPLDPNSPYAASKASSDLLALAFHRTHGLDVRVTRCSNNYGPHQHPEK
>chalcomycin_2
VLVTGALGFIGSHFVRQLEARGAEVLALYRTERPQLQAELAALDRVRLIRTELRDESDVRGAFKYLAPSIDTVVHCAAMDGNAQFKLERSAEILDSNQRTISHLLNCVRDFGVGEAVVMSSSELYCAPPTAAAHEDDDFRRSMRYTDNGYVLSKTYGEILARLHREQFGTNVFLVRPGNVYGPGDGYDPSRGRVIPSMLAKADAGEEIEIWGDGSQTRSFIHVTDLVRASLRLLE
>BE_7585A_1
VLVVGPTGNVGPHALAQLLEAGVAARALVPPGDPAVARIPDGTEVFEGDLADPESLVPALDGVTGVFLMWPFFTLDVSTAPAVLEVISRYTGRVVFVSSIGVHIGLEPVDNNCHAYLEQQIEKAGLTWTFLQTTGFACNALGWAGQLDGGDVVRFPYGGAVRTPVHEADLAAVGVRALT
>BE_7585A_2
ILVTGGAGFIGSAYVRGLLAGAYPGTDGARVTVLDNLGYAGRRDNLPAAHPRLEFAEGDVRDTALLAALVPGHDLVAHFAAESHVDRSLAAAGDFLRTNVEGTGAVLQACADARVARVVHVSTDEVYGSIDDGAWTEDSPLLPNSPYAASKAASDLVARAYWRTHGLDVSITRCCNNYGPRQHPEKVI
>versipelostatin_1
SAFRREEELVRSTIQQCLERRHRLVFLSTASAGMYGAPGCRGREDDPVLPVSAFGRHKLELESVIRDSGVRALILRLGHVVGPGQRDYQLVPALARQLRAG
>versipelostatin_2
ILVTGGAGFIGSHYVRTLLGPDGPADVTVTVLDKLTYAGNPANLDPVRGSGRFRFVRGDICDAELVDALVAEHDEVVHFAAESHVDRSIQGAAEFVRTNVAGTQTLLDAALRHAPDVFVHISTDEVYGSIPSGSWPETDPLQPNSPYSAAKASSDLIALAYHRTHGLDVRVTRS
>apramycin_1
IFVTGAAGYVGQAVLARLLAAGHDVTAVGHRTPVGWPAGTPSRQADLTDAPAVLRALDGAEAVCHLAGLTRVRGSGVDVDRYYRVNVVGTLNVLDALVARHRAGDGPARLVFLSSGAVYGRTGDAPVREDHPTLPTSAYGATKLAAEQAVGWYAGTGALSAVSLRLFTAAGSVRPGCRPDDSTLVARALSVAAGENAVLPVNGDGSTVRDFVHVADVADAVARAVE
>apramycin_2
MITGGTGSLGRAFIRNALDTLGCDSVVVYSRDELKQRELREAFDHDRRLEWVIGDVRDPDRLRHAMRDVEHVVHAAALKQVDTAERNCIEYIRTNVLGAQNVIDAAVETGVSRVVALST
>apramycin_3
VLITGGAGYIGSVLTRRLLDKRVRVRVLDSRIFGDGLRDLADPGLENVQGDIRDADLFRTALRDVDVVVHLAAVANDPSFDLNPELGRSVNFECLDHVMRLSKEAGVRRFVYASSASVYGISDSPEVDESHPLVPITDYNRYKALGEEILFPLTDTSFETVALRAATVCGVSTRQRLDLTV
>warkmycin_1
VVVLGGTGCIGRHICAAFADQGYRVVTVARRPAPRVTPHPHRTLDLQTAGPPVLRALFDDERADVVVNATDMAGATDTTGVADGGEARAAELLDANEGLSRRLVDALSGAARAPRLVHIGTIHEYGPGDSGVPLREDVEPAPVNAYARAKLAGSRAVLDAARSGAVSAVVLRLVNTCGPYPTPAGFAGKLLPTLRAAAAAGEAPEITVGAAMRDWIDVRDIAGAAVLA
>warkmycin_2
VSWAAHTSPADFAREAALVEEKIAACLASGERLVFFSTASTGMYGKVDGPGREDRPVVPCTPYGTHKLALEKRLEASGVDYLALRLGHLVGPGQPPHQLLPTLVRQMRSGTV
>warkmycin_3
LVTGGAGFIGSRFVRMLLENRFEGWEDAEVVVLDALTYAGNRANLPASHPRLRFVRGDVCDTETVRELADGVHAVVHFAAESHVDRSLTGPAEFYRTNVLGTQSVLEAALRADVERVVHVSTDEVYGSISEGSWTEDRPLAPNTPYAASKAASDLVARSYWRTHGLDVSVTRCSNNYGPRQHPEKL
>pradimicin_1
ILVTGGAGFIGSHYVRSVLAGRYPAVADALVTVVDKLTYAGNTDNLPIGDPRLTFVKGDICDVPLLRELLPGHDAVVHFAAESHVDRSLVSAGEFAVTNVLGTQSLLDCCVLAGIGRVVHVSTDEVHGSIDTGSWDEAAPVDPRSPYAASKAASDH
>lactomycin_1
VVVLGATGFLGRHICAALRDAGRPVRAVARSGPTPVDLLHSAPQTLAAVFDEADAVVNAAGRAWQADARDMERGNVLVVRTVLDALRLTDRRPRLIQLGSVHEYGTAEPGTAMAESRPPRPLTPYGRTKLEATRAVLDAVDRRRLDATVLRVANVCGPGAPRGSLFGLVAAAVHEARQARRADRTPPALRVSPLRAHRDVVDVRDVADAVVAA
>lactomycin_2
VTGGAGFIGSAYVRAVLDGALPDSATVDVTVLDKLTYAGSRDNLPARHPRLEFVRGDVCDLPLLLDVLPGHDAVLHFAAESHVDRSIEASAAFVHTNVGGTQSLLEACRRTGVERVVHVSTDEVYGSIAEGSWTEEWPLRPNTPYAASKAASDLVARSYWKTHGLDVSITRCSNNYGPHQHPEKL
>heterocyst_glycolipids_1
IFLTGGTGFLGAFIIRELLQETNADIYCLVRAANAEEGKSKLQKNLEQYAIWQEEFNSRIIPIVGDLSQPLLGIGSEQFQILAGNIDTIYHSAALLNYVFPYSALKAANVLGTQEVLRLACQIKVKPVHYVSSVAVFESTAYAGKVVKEQDEFNHWEGIYLGYSQTKWVAEKLVKIARDRGLPVTIHRPPLISGDSK
>medermycin_1
VLVTGGAGFIGSHYVRTMLAGGYPGYEDARITVVDKLSYAGNRDNLPADHPRLDFVQGDVCDLPLLLDVFPGHDGLVHFAAESHVDRSVESAAEFVRTNVGGTQTVLDACVETGIERVVHVSTDEVYGSIETGSWTESRPLLPNSPYAASKAGADLVARSYWRTHRLDLSITRCSNNYGSHQH
>medermycin_2
VMVLGGTGFVGRTVCADFRAAGWDVLAVARTAPERPAATRFLALDLAETPSATLARVLEAERPDVVVNATGSIWSRDDAAMERICTVPTLRLLDALATLRHRPRLVHLGTVLEYGPLPPDGTPRPDPAPEPTTPYGRAKLAPSRAVLEAAASGAVRALVLRVSNVSGVG
>medermycin_3
VVTGATSGIGWEIAVRLAETGHRVYLCARSADRLAEAVKQLQDRGFDADGSTCDVADPAQVTAFVTAAVA
>diazepinomicin_1
VVVVGGTSGIGRHFARFCAERGDDVVITGRSAARTKTVADEIGGRTRGLALDLAEPERIADALADVPHVDRLVVAALDRDHNTVRAYRPGDAARLLTVKLVGYTAVLHALAPRMTDESAVVLLGGLASHRPYPGSTTVTTANGGISALVRTLAVELSPIRVNALHPSIVSDTPFWSD
>cetoniacytone_1
LVTGASKGIGLAVVQALAAEGVRVAACARTTSEALAEATPLTRQIDLSDAGQTAEMVDWALGELGGIDLLVNNVGGSPARTDGFLAISDEEWQHAFELNFFSAVRTTRAALPSLLERKGNIVNIGSVNSQLALPRLIDYSAAKAAM
>validamycin_1
ILILGSGYLAGHIAARLTRLGAETVLSSRRAPVLPESRGVRWKQVDVTSGPQVAALMDAVEPDAVVAVHGPSDITWCESHPEEAYATHHGGARNIAAALDGRPVLLVSTDNVFSGEDESYGESAQTFPVNAYGRAKLAAERELLDTSSALVLRVSLVYGW
>staurosporine_1
ILVTGGAGFIGSHFVRSYADQDELTVLDKLTYAGNLANLEPVEGRFTFVHGDIGDAALVAEVVPGHDLVVNFAAESHVDRSIADADEFVHSNVLGVQTLMRACLDAGTPRVVHVSTDEVYGSIDTGSWDETAPLNPNSPYAAAKAGGDLIALAHARTHGLPVSITRCGNNYGP
>staurosporine_2
ITVLGASGFVGSAVTRALASRPVRLRLVSRRPCVPSPGPAETDVVTADLTDRAALAGAVHGSDAVIHLLLGEGGWRAAESDPGAEHVNVGVMRDLVDVLRPAPGDATPPLVVYAGAASQVGVPPREPLDGSEPDRPGTAYDRQKLTAEHLLLKATAEGRVRGIGLRLPTVFGESTAPGAGDRGVVSAMARRALDGQTLTMWHDGTVRRDLVHVDDVAAAFTAALD
>clorobiocin_1
LVTGAAGMLGRDLVGVLQGLNESVVAVTRQDLDITDRFSVRAVVSRYQPTTIVNCAAWTRFPEAEVSESEALLINGRGVRELASICSDRSIRLVHLSTDYVFDGTSCQPYAESAATSPINAYGRTKLAGEQAVLELLPDDGTIVRTAWLYGRHGTNFI
>clorobiocin_2
LVTGGAGFIGSEFVRATLRGVLPGSSGTHITVLDKLTYSGNELNLAPIADLPNYRFVQGDICDRGLVDDVVAGHDAIVHFAAETHVDRSIDSAASFVRTNALGTQVLLEAASRHRLGRFVHISTDEVYGSIPEGAWTEVSPVAPNAPYAAAKAAGDLLALAWHRTRRLDVVVTRCTNNY
>acarbose_1
LVVGGTTGIGRGIADAWAAAGAEVTVCGRSEPAGDGAAGLHWEPLDLTRTGEAGARLERIAGDRVDLACFAAVSYGARRAVFEDVAVDEWRTQLDINVHGLWLTLRAALPGLRAARPGLFVGVSSEVVYNAGPGRSGYTASKAAAKALLESVAQEEDESRVRIVQVLPAGMVDTP
>acarbose_2
ILVTGGAGFIGSHFVTSLISGDIATPQPVTQVTVVDKLGYGGNLRNLAEASADPRFSFVRGDICDEGLIEGLMARHDTVAHFAAETHVDRSVVASGPFVASNLVGTQVLLDAALRHHIGRFLHVSTDEVYGSIDTGSWAEGHPLAPNSPYAASKAGSDLLALAYHQTHGMDVVVTRCSN
>nystain_like_polyene_1
LITGITGQDGSYLAEHLLSQGYQVWGLIRGQANPRKTRVSRLASELEFVDGDLMDQASLVSAVDTVQPDEVYNLGAISFVPMSWQQAELVTEVNGTGVLRVLEAIRMVSGLSMSRTASP
>meridamycin_2_1
LVTGGTGALGRQVARWLVDSGVERIVLTSRRGAEAPGAAELVAELGSRVRVVACDVADREALAALLSTIPDLRTVVHAAGVLDDGVLESLTPERIRAVMRAKADGARHLHELTNGTDLDAFVLFSSAAGTVGNAGQGSYAAANAVLDGLAQRRRAEGLVAT
>auricin_deoxysugar_moieties_1
LVTGGAGFIGSHFVRTLLDGGYPGHEEDRVTVLDKLTYAGNRENLPAAHPRLDFVRGDVCDEALLRSLLPGHDAVVHFAAESHVDRSVHSAAEFVRTNVGGTQTLLDACLATGVGRVVHVSTDEVYGSIDEGAWTEERPLLPNSPYAASKASSDLIARAYWRTHGLDVSITRCSNNYGPHQHPEKLIP
>cosmomycin_1
VAVLGATGCVGRSVCDELSRTGHRVLAVARHPAPHTRPHAFVPLDVAGTAPERLAALLDRYGVTAVVNATGGWGTTVEEMRRAHIDLLERLVDGCAATSRRLRVV
>cosmomycin_2
ILVTGAAGFIGSHFVRTLLSGGYPGHEDDRVTVLDKLTYAGTLNNLPAHHPRLTFVHGDICDTTLLDKVFPGHEAVVHFAAESHVDRSVAGAEAFVRTNVLGTQALLEAALRHGIGVFVQVSTDETYGSIAEGRWTEDEPLLPNSPYAASKASADLIARSYWRTHGLDVRITRCANNYGPGQHPEK
>U_68204_1
VVITGGTGTIGRALARHLVTRKSVRSVALLSRSGRQAPGITALTSDLERLG
>aculeximycin_1
VLITGGTGALGRQVAAWLLDNGAEHVVLTSRRGGEAPEFGDRATVVACDMSDRAAVENLLAATEFSAVVHAAGVLDDGVLD
>aculeximycin_2
VLISGGTGALGRQVAQWLLDNGAEHVVLASRRGGTAPEFGDRASVVACDIANRAALEILLSKHEFTAVVHAAGVLDD
>aculeximycin_3
VLVTGGTGGLGAQVARHLVTEHGARDLLLLSRTGSAPELAAELTELGASVRIAACDVADRDALAAVLDGVALTGVVHTAGVVDDGVIASLDQARVDKVLRPKVDAVVNLHELTQGQDLAMFVVFSGAAGVFGGPGQGNYAAANVFLDAFAQH
>aculeximycin_4
LITGGTGGLGAQVARWMAEHGAERLVLTSRRGADAPGAAELAAELGDRVRIVACDIADREAVAELLASIEDLRSVVHAAGTTTFTPLAEITPEELATLGAAKVQGARHLDELLADRELDAFVLFSSIA
>aculeximycin_5
VLITGGTGALGAHVARRLARMGAEHLVLASRRGAQAPGAEELRAELVELGARVTISACDTGSRAAVSALLAAVPDLTAVVHTAGVLDDGVLDAMTPDRFETVFGPKVTAAKHLHELTRDLDLSAFVLFSSAVGTLGNAGQGNYAAANAYLDALAVQRRAEGLPATSIAWGQW
>aculeximycin_6
VLITGASGTIGSLVARHLVTERGARKLVLASRRGPAPELVAELTGLGAEVEPAACDVAVREQVADLLDRVTDLDAVVHLAGTLDDGVLTSLTPERVDTVLRPKADAALHLHELTRDRELSAFVLFSSLAGTTGSPGQGNYAAANAFLDALAVRRRAE
>aculeximycin_7
VLITGGTGALGRQVARWALDNGAEHVVLMSRRGGEAPEFGDSATVIACDAADRDALAAVLADLDLSAVVHAAGVLDDGVLDTVTPERLAAVLKSKVDSARNLHELTGDLD
>aculeximycin_8
VLVTGGTGGLGAEVARHLVTEHGARDLLLLSRRGSAPELAAELTELGATVRIAACDVADRDALAAVLDGVRLTGVVHTAGVVDDGVIVALDGQRVDKVLRPKVDAVVNLHELTAGADLSMFVTFSSAAGVLGNAGQSNYAAANVFLDAFAQHRRA
>aculeximycin_9
ILVTGGAGFIGSHYVRQLVGGAYPAYAEAEVVVLDKLTYAGNLANLAPVDTSSRLRFVQGDICDPAVVSEVMAGTDLVVHFAAESHVDRSIAGSADFVLTNVLGTQMLLQGALDAGVGKFVHVSTDEVYGTIETGSWPETHPLEPNSPYSASKASSDLLARSFHRTHGLPVCITRCS
>cervnimycin_1
VVVLGGTGFVGRHVCAALLSEGEGEGKGKGPDVVAVSRRPGPPPSGPRPLALDLCRTPPAELADALTGDRPTLVVNAAGAVWAATEEHMVAANTELVRRLVDALRRARRPVRLVHLGSVNEYTPSADGRPVDEGTPTRPTTAYGRTKLAGTELVLEAARRGDIDALVLRMANVAGPGSPPA
>cervnimycin_2
VLVTGGAGFIGSCYVRALLDGAYPGYEDAQVTVVDKLTYAGNRANLPERHERLRFVVGDIADREALRAVVEGHDEVVHFAAESHVDRSLHDASDFVRTNVAGTQSLLEACLRAEVRRVVHVSTDEVYGSIESGEWTESSPLLPNSPYAATKASGDLIARAYWRSYGLDVRVT
>haliamide_1
LITGASGGLGQALAQHLVARGAEELVLVSRTAPPAELLDTLPATFIVADVSEPGALEAVLLRAGALDGVVHAAGQLSDGVLLQLDAAAFATVSGPKLAAARQLAEALPLPTRLVLFSSVSAW
>A_503083_1
LIGAGFLGNALALGAARRGWSATVISRSDPFATRDADPGPGEIRLLSGEGADCLPQALDPSVDAIVIAAGGRFPLPSTTAPAADAIGTLSLVIELCEKVRSLSPGTRIVFLSSAGAVYAPADELKRESDPGQPTSPYGMSRRMGEEYMAYYRRVHGLSTLSLRCVNVYGRLLPRSRGQGVVSAAFRSALSGVPFTLHGNGRQTRDFIHVDDFVTATLDVI
>A_503083_2
VLVTGGAGFIGSAYVRELLSGAYPAWQAAQVTVLDLLTYAGNLANLAPVDGRFTFVHGDIGDRALLEKVVPGHDAVVSFAAESHVDRSIAGAADFLRTNVLGVQRLFDACLEAGVGRVVHVSTDEVYGSIGSGSWDETAPLAPNSPYAASKASSDLLARS
>A_503083_3
IAVTGGLGRIGRAVGAELSGHGHETVLVDVAPMRAQGPGYRRADLRELWQAVDALDGVDAVVHLAATGVPDSHTVHPELAEGATYAANATSTYNVFQAAAVHGIERVVWASSETVLG
>A_503083_4
VIVTGAAGRIGSGFAEFAADRFELLLLDRPGADLSGLGAYGRTEHCDLSDLPRLTELCRGADCVLHLAADSHTAAEWDSLLATNIVGTYHMFTASKTAGCPRVVFASSVHAVSGYTPGRQISPDAPVNPGNLYGVSKCFGEALGRYMAEREGLTVMAVRIGAFQKPDAAS
>granaticin_1
LVTGAAGFIGSHYVREILAGSYPESDDVHVTVVDRLTYAGRRDNLPEHHERLDFVHGDICDRDLLDRVLPGHDAVVHFAAESHVDRSLTGPGEFVRTNVMGTQQLLDAALHAGVDRVLHVSTDEVYGSLDSGTWTEDSPLLPNSPYAASKASTTWSAAPTTVRHGLDVRITRCSNNYGPRQHPEKLIPN
>granaticin_2
VLVLGGSGFVGRHVCAAFLARGWEVHGWARHDRGAPGVTTRAVDLVRAEPGRLADELAAVAPDTVVNASGAVWGVTETEMADANQALVSRVLTALGAAPSPRFVQLGTVHEHTAATAYGRTKAAATARVLAAGGTVLRLPNLLGP
>nonadecene_1
LVTGGLGAIGRKIAQWLAAAGAEKVILVSRRAPAADQQTLPTNAVVYPCDLADAAQVAKLFQTYPHIKGIFHAAGTLADGLLQQQTWQKFQTVAAAKMKGTWHLHRHSQKLDLDFFVLFSSVAGVLGSPGQGNYAAANRGMAAIAQYRQAQGLPALAI
>fostriecin_1
VVVLGVTSALGRRLAESILARGLTPVGLIGEAGHSESLRAAGTEPLVIASEADRTSPAALRAMGECGGIAVATGTGWGPDATDTSSTSLVGELMGVAQLVGIRRFVLVSAYLPDDELHTRLGDELESYLAEKRDVERKLAGHDLDWCVVRPGMLDNSPATGLVTVRGGADPQPEGTVSRTDLAETICEAL
>fostriecin_2
VLITGGTGALGSRLARRLAAQGAQHLLLTSRRGPEALDADGLGADLESMGARVTIAACDLADREAVRALLESV
>borrelidin_1
MVTGAGSGIGRAAARLLVGHGARVVLVGRTESALTETTAGLPSSHHLVVPCDVGDDKQVADCVAR
>borrelidin_2
VLITGGSGALAGIVAQHLVARHGVRRLVLASRSGRPAPGADLLDADVTAVSCDVSDRDAVAALLASVPDEHPLTAVVHTAGVLDDGVLHALTTERIDTSFAAKVDGARHLHELTSHLDLTAFVLFSSASAVLGAAGQGNYAAANAYLDALAAHRRSNDLPAVSLA
>borrelidin_3
VLLFGATGGVGVACAQLALRAGARIIACSGSPAKLARLRRLGVIDTIDTGTEDVRRRVRELTDGGADLVVDYQG
>mithramycin_2_1
ILVTGGAGFIGSHYVRTLLGPRGVPDVTVTVLDKLTYAGTLTNLAEVSDSDRFRFVRGDICDAPLVDDLLAVHDQVVHFAAESHVDRSILGAADFVRTNVTGTQTLLDAALRQGIETFVHISTDEVYGSIDAGSWPETAPVSPNSLYSAAKASSDLVALAYHRTHGLDVRVTRCSN
>mithramycin_2_2
VLVTGGSSGIGAAVARAYADEGARVALTYRGGDEAAERLARELGAGRHAAMAVRYSLGEPDTVESAVATVTERWGGVDVLVANAVRWAPRRAPGTRFEEVASGDWRGFLDDNLAPTLRTVQLVVAGMRARSWGRIVLISSHVALDGHRGQEFYGAAKSALHGFARSLAWDVGRDGVLVNVVCPGLTTTER
>mithramycin_2_3
VVVTGGGSGIGRATARAYAAQGAHVLVVGRTAGHLEETAEGQPRIRAFVADLADRDAPERIVAAALDATGGIDVLVNNAAVPWRARLGEIDRERAE
>chartreusin_1
LVVGAGGLMGRALCQRLRASGAEAVAATRDTPPLVRPDGTPAPALRAAGVVHYLATSVTPGLAETHPERVAADHETFVRTLDALATVEKPPLVVLASTGLTVSESGDGRPCTEDAEALPKSAYARAKLALERELLYRSPLVPGMVVRMTNVYGPGH
>kijanimicin_1
ITVLGASGFVGSAVTAALARRRCRVRAVARRPGAPVRPGAAEMEWCAADLTDTAQLARALAGSDAVLHLLLNDGGWRAAENDPGSERLNVGVMRALLEELAARDGRRPPALVVYAGAASQIGVPPDGPIDGSEPDAPLARYDRQKLAAERLLKEAS
>kijanimicin_2
VVVTGGAGFIGSHYVRQLVTGAYPAFADASVVVLDKLTYAGNEENLAPVSDDRRFELVVGDVCDGELLAEVLPGADVVVHFAAESHVDRSIVGSTDFMQTNVLGTHSVFQACLDAGVKRVVQVSTDEVYGSIEAGSWTEDEPLEPNSPYSASKAAADLVARS
>phenalinolactone_1
LVTGAAGFIGSAYVRMLLAPGPVEVSHVTVLDKLTYAGRIDNLDVTHPRLSFVQGDICDAALVDRLMSRADQVVHFAAESHVDRSIAGADAFVRTNVTGTQTLLDAALRRGVGRFVHVSTDEVYGSVAAGRFTEEDTLGPTSPYAASKAGSDLVALSYHRTHGLDVRVTRCSN
>phenalinolactone_2
VAVLGASGFLGAAVTAELIDAPVRLRLVSRERKLPLPASSAETHLADLTDPRAVRVAVDGADAVIHLAAHLPDGRSWRAPGSDSERLSTGLLDTLVRSVRGKPPIVVFASTIQAAAPEGTPLNDYVREKIAAEKVLREATRNGAVRGIVLRPATVYGSTPLTGATGRGVVAAMARKAFADEPITMWHDGTVERDLVHVTDTARAFVAA
>K_252a_2_1
ILVTGGAGFIGSHFARGLGGAEVTVLDKLTYAGNRANLDGVPHAFVHGDICDAGLLREVLPGHDLVVNFAAESHVDRLIEGAAEFVRTNVLGTQTLLQGCLEAGVRKVVQVSTDEVYGSIGVGSWTESAPLRPRSPYAAAKAGGDLVAQAYAITHGLDVSITRCGNNYGPRQYPEKI
